{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:59:56Z","timestamp":1793314796297,"version":"4.5.0"},"reference-count":300,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Hannover (MHH)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by the progressive degeneration of both upper and lower motor neurons. A defining histopathological feature in approximately 97% of all ALS cases is the accumulation of phosphorylated trans-activation response (TAR) DNA-binding protein 43 protein (pTDP-43) aggregates in the cytoplasm of neurons and glial cells within the central nervous system. Traditionally, it was believed that the accumulation of TDP-43 aggregates and subsequent neurodegeneration primarily occurs in motor neurons. However, contemporary evidence suggests that as the disease progresses, other systems and brain regions are also affected. Despite this, there has been a limited number of clinical studies assessing the non-motor symptoms in ALS patients. These studies often employ various outcome measures, resulting in a wide range of reported frequencies of non-motor symptoms in ALS patients. The importance of assessing the non-motor symptoms reflects in a fact that they have a significant impact on patients\u2019 quality of life, yet they frequently go underdiagnosed and unreported during clinical evaluations. This review aims to provide an up-to-date overview of the current knowledge concerning non-motor symptoms in ALS. Furthermore, we address their diagnosis and treatment in everyday clinical practice.<\/jats:p>","DOI":"10.1007\/s00415-024-12455-5","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T06:02:02Z","timestamp":1716876122000},"page":"3953-3977","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Non-motor symptoms in patients with amyotrophic lateral sclerosis: current state and future directions"],"prefix":"10.1007","volume":"271","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1783-703X","authenticated-orcid":false,"given":"Bogdan","family":"Bjelica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maj-Britt","family":"Bartels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Hesebeck-Brinckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"12455_CR1","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, Sobue G (2022) Amyotrophic lateral sclerosis. Lancet 400:1363\u20131380","journal-title":"Lancet"},{"key":"12455_CR2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","volume":"41","author":"A Chio","year":"2013","unstructured":"Chio A, Logroscino G, Traynor BJ, Collins J, Simeone JC, Goldstein LA, White LA (2013) Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology 41:118\u2013130","journal-title":"Neuroepidemiology"},{"key":"12455_CR3","doi-asserted-by":"crossref","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman O, Al-Chalabi A, Chio A, Corr EM, Logroscino G, Robberecht W, Shaw PJ, Simmons Z, van den Berg LH (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071","journal-title":"Nat Rev Dis Primers"},{"key":"12455_CR4","doi-asserted-by":"crossref","unstructured":"Chio A, Battistini S, Calvo A, Caponnetto C, Conforti FL, Corbo M, Giannini F, Mandrioli J, Mora G, Sabatelli M, Consortium I, Ajmone C, Mastro E, Pain D, Mandich P, Penco S, Restagno G, Zollino M, Surbone A (2014) Genetic counselling in ALS: facts, uncertainties and clinical suggestions. J Neurol Neurosurg Psychiatry 85:478\u2013485","DOI":"10.1136\/jnnp-2013-305546"},{"key":"12455_CR5","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/ng.132","volume":"40","author":"E Kabashi","year":"2008","unstructured":"Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, Bouchard JP, Lacomblez L, Pochigaeva K, Salachas F, Pradat PF, Camu W, Meininger V, Dupre N, Rouleau GA (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40:572\u2013574","journal-title":"Nat Genet"},{"key":"12455_CR6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.21147","volume":"61","author":"IR Mackenzie","year":"2007","unstructured":"Mackenzie IR, Bigio EH, Ince PG, Geser F, Neumann M, Cairns NJ, Kwong LK, Forman MS, Ravits J, Stewart H, Eisen A, McClusky L, Kretzschmar HA, Monoranu CM, Highley JR, Kirby J, Siddique T, Shaw PJ, Lee VM, Trojanowski JQ (2007) Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations. Ann Neurol 61:427\u2013434","journal-title":"Ann Neurol"},{"key":"12455_CR7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1750-1326-7-53","volume":"7","author":"C Verbeeck","year":"2012","unstructured":"Verbeeck C, Deng Q, Dejesus-Hernandez M, Taylor G, Ceballos-Diaz C, Kocerha J, Golde T, Das P, Rademakers R, Dickson DW, Kukar T (2012) Expression of Fused in sarcoma mutations in mice recapitulates the neuropathology of FUS proteinopathies and provides insight into disease pathogenesis. Mol Neurodegener 7:53","journal-title":"Mol Neurodegener"},{"key":"12455_CR8","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0b013e3181b6bbbd","volume":"73","author":"JM Ravits","year":"2009","unstructured":"Ravits JM, La Spada AR (2009) ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration. Neurology 73:805\u2013811","journal-title":"Neurology"},{"key":"12455_CR9","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrneurol.2013.221","volume":"9","author":"H Braak","year":"2013","unstructured":"Braak H, Brettschneider J, Ludolph AC, Lee VM, Trojanowski JQ, Del Tredici K (2013) Amyotrophic lateral sclerosis\u2013a model of corticofugal axonal spread. Nat Rev Neurol 9:708\u2013714","journal-title":"Nat Rev Neurol"},{"key":"12455_CR10","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/ene.12706","volume":"22","author":"AC Ludolph","year":"2015","unstructured":"Ludolph AC, Brettschneider J (2015) TDP-43 in amyotrophic lateral sclerosis - is it a prion disease? Eur J Neurol 22:753\u2013761","journal-title":"Eur J Neurol"},{"key":"12455_CR11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/WCO.0000000000001098","volume":"35","author":"K Del Tredici","year":"2022","unstructured":"Del Tredici K, Braak H (2022) Neuropathology and neuroanatomy of TDP-43 amyotrophic lateral sclerosis. Curr Opin Neurol 35:660\u2013671","journal-title":"Curr Opin Neurol"},{"key":"12455_CR12","doi-asserted-by":"crossref","unstructured":"Shojaie A, Rota S, Al Khleifat A, Ray Chaudhuri K, Al-Chalabi A (2023) Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson\u2019s disease. Amyotroph Lateral Scler Frontotemporal Degener 2023:1\u201310","DOI":"10.1080\/21678421.2023.2263868"},{"key":"12455_CR13","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/bs.irn.2017.04.009","volume":"134","author":"T Fang","year":"2017","unstructured":"Fang T, Jozsa F, Al-Chalabi A (2017) Nonmotor symptoms in amyotrophic lateral sclerosis: a systematic review. Int Rev Neurobiol 134:1409\u20131441","journal-title":"Int Rev Neurobiol"},{"key":"12455_CR14","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/21678421.2023.2263868","volume":"25","author":"A Shojaie","year":"2024","unstructured":"Shojaie A, Al Khleifat A, Opie-Martin S, Sarraf P, Al-Chalabi A (2024) Non-motor symptoms in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 25:61\u201366","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR15","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1001\/archneur.1983.04050070083025","volume":"40","author":"ME Drake Jr","year":"1983","unstructured":"Drake ME Jr (1983) Chronic pain syndrome in amyotrophic lateral sclerosis. Arch Neurol 40:453\u2013454","journal-title":"Arch Neurol"},{"key":"12455_CR16","doi-asserted-by":"crossref","first-page":"897598","DOI":"10.3389\/fnins.2022.897598","volume":"16","author":"R An","year":"2022","unstructured":"An R, Wu Y, Li Y, Li X, Ai S, Xu Y, He C (2022) Pain-related factors and their impact on quality of life in Chinese patients with amyotrophic lateral sclerosis. Front Neurosci 16:897598","journal-title":"Front Neurosci"},{"key":"12455_CR17","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.21037\/apm-20-864","volume":"10","author":"Z Kong","year":"2021","unstructured":"Kong Z, Chen P, Jiang J, Wang X, Wang Y, Shi Y, Zhao B, Zhu J (2021) Pain characteristics in amyotrophic lateral sclerosis patients and its impact on quality of life: a prospective observational study in a northern city of China. Ann Palliat Med 10:1668\u20131674","journal-title":"Ann Palliat Med"},{"key":"12455_CR18","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1468-1331.2011.03540.x","volume":"19","author":"A Chio","year":"2012","unstructured":"Chio A, Canosa A, Gallo S, Moglia C, Ilardi A, Cammarosano S, Papurello D, Calvo A (2012) Pain in amyotrophic lateral sclerosis: a population-based controlled study. Eur J Neurol 19:551\u2013555","journal-title":"Eur J Neurol"},{"key":"12455_CR19","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3109\/21678421.2014.951944","volume":"15","author":"VC Wallace","year":"2014","unstructured":"Wallace VC, Ellis CM, Burman R, Knights C, Shaw CE, Al-Chalabi A (2014) The evaluation of pain in amyotrophic lateral sclerosis: a case controlled observational study. Amyotroph Lateral Scler Frontotemporal Degener 15:520\u2013527","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR20","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1080\/09638288.2018.1555615","volume":"42","author":"Y Akerblom","year":"2020","unstructured":"Akerblom Y, Jakobsson Larsson B, Zetterberg L, Asenlof P (2020) The multiple faces of pain in motor neuron disease: a qualitative study to inform pain assessment and pain management. Disabil Rehabil 42:2123\u20132132","journal-title":"Disabil Rehabil"},{"key":"12455_CR21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1590\/S0004-282X1999000500006","volume":"57","author":"CM de Castro-Costa","year":"1999","unstructured":"de Castro-Costa CM, Oria RB, Machado-Filho JA, Franco MT, Diniz DL, Giffoni SD, Santos TJ, da Cunha FM, de Bruin VS, Teixeira CA (1999) Amyotrophic lateral sclerosis. Clinical analysis of 78 cases from Fortaleza (northeastern Brazil). Arq Neuropsiquiatr 57:761\u2013774","journal-title":"Arq Neuropsiquiatr"},{"key":"12455_CR22","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1007\/s00415-015-7672-0","volume":"262","author":"A Truini","year":"2015","unstructured":"Truini A, Biasiotta A, Onesti E, Di Stefano G, Ceccanti M, La Cesa S, Pepe A, Giordano C, Cruccu G, Inghilleri M (2015) Small-fibre neuropathy related to bulbar and spinal-onset in patients with ALS. J Neurol 262:1014\u20131018","journal-title":"J Neurol"},{"key":"12455_CR23","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/ene.12936","volume":"23","author":"E Dalla Bella","year":"2016","unstructured":"Dalla Bella E, Lombardi R, Porretta-Serapiglia C, Ciano C, Gellera C, Pensato V, Cazzato D, Lauria G (2016) Amyotrophic lateral sclerosis causes small fiber pathology. Eur J Neurol 23:416\u2013420","journal-title":"Eur J Neurol"},{"key":"12455_CR24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/21678421.2015.1074701","volume":"17","author":"HE Stephens","year":"2015","unstructured":"Stephens HE, Lehman E, Raheja D, Yang C, Walsh S, McArthur DB, Simmons Z (2015) Pain in amyotrophic lateral sclerosis: Patient and physician perspectives and practices. Amyotroph Lateral Scler Frontotemporal Degener 17:21\u201329","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR25","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.296","volume":"5","author":"F Hanisch","year":"2015","unstructured":"Hanisch F, Skudlarek A, Berndt J, Kornhuber ME (2015) Characteristics of pain in amyotrophic lateral sclerosis. Brain Behav 5:e00296","journal-title":"Brain Behav"},{"key":"12455_CR26","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.pmr.2005.08.015","volume":"16","author":"AJ Hoffman","year":"2005","unstructured":"Hoffman AJ, Jensen MP, Abresch RT, Carter GT (2005) Chronic pain in persons with neuromuscular disease. Phys Med Rehabil Clin N Am 16:1099\u20131112, xii","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"12455_CR27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jns.2007.09.027","volume":"267","author":"Y Abe","year":"2008","unstructured":"Abe Y, Miyashita M, Ito N, Shirai Y, Momose Y, Ichikawa Y, Tsuji S, Kazuma K (2008) Attitude of outpatients with neuromuscular diseases in Japan to pain and use of analgesics. J Neurol Sci 267:22\u201327","journal-title":"J Neurol Sci"},{"key":"12455_CR28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S1474-4422(16)30358-1","volume":"16","author":"A Chio","year":"2017","unstructured":"Chio A, Mora G, Lauria G (2017) Pain in amyotrophic lateral sclerosis. Lancet Neurol 16:144\u2013157","journal-title":"Lancet Neurol"},{"key":"12455_CR29","doi-asserted-by":"crossref","unstructured":"Beswick E, Forbes D, Johnson M, Newton J, Dakin R, Glasmcher S, Abrahams S, Carson A, Chandran S, Pal S (2024) Non-motor symptoms in motor neuron disease: prevalence, assessment and impact. Brain Commun 6:fcad336","DOI":"10.1093\/braincomms\/fcad336"},{"key":"12455_CR30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/21678421.2021.1892765","volume":"22","author":"N Hurwitz","year":"2021","unstructured":"Hurwitz N, Radakovic R, Boyce E, Peryer G (2021) Prevalence of pain in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotroph Lateral Scler Frontotemporal Degener 22:449\u2013458","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.12701\/jyms.2022.00332","volume":"39","author":"S Kwak","year":"2022","unstructured":"Kwak S (2022) Pain in amyotrophic lateral sclerosis: a narrative review. J Yeungnam Med Sci 39:181\u2013189","journal-title":"J Yeungnam Med Sci"},{"key":"12455_CR32","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/j.amjmed.2009.04.006","volume":"122","author":"ML Haanpaa","year":"2009","unstructured":"Haanpaa ML, Backonja MM, Bennett MI, Bouhassira D, Cruccu G, Hansson PT, Jensen TS, Kauppila T, Rice AS, Smith BH, Treede RD, Baron R (2009) Assessment of neuropathic pain in primary care. Am J Med 122:S13-21","journal-title":"Am J Med"},{"key":"12455_CR33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.neulet.2011.08.014","volume":"503","author":"Y Mochizuki","year":"2011","unstructured":"Mochizuki Y, Mizutani T, Shimizu T, Kawata A (2011) Proportional neuronal loss between the primary motor and sensory cortex in amyotrophic lateral sclerosis. Neurosci Lett 503:73\u201375","journal-title":"Neurosci Lett"},{"key":"12455_CR34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.5414\/NP300859","volume":"34","author":"K Oyanagi","year":"2015","unstructured":"Oyanagi K, Mochizuki Y, Nakayama Y, Hayashi K, Shimizu T, Nagao M, Hashimoto T, Yamazaki M, Matsubara S, Komori T (2015) Marked preservation of the visual and olfactory pathways in ALS patients in a totally locked-in state. Clin Neuropathol 34:267\u2013274","journal-title":"Clin Neuropathol"},{"key":"12455_CR35","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/jmri.22053","volume":"31","author":"J Han","year":"2010","unstructured":"Han J, Ma L (2010) Study of the features of proton MR spectroscopy ((1)H-MRS) on amyotrophic lateral sclerosis. J Magn Reson Imaging 31:305\u2013308","journal-title":"J Magn Reson Imaging"},{"key":"12455_CR36","doi-asserted-by":"crossref","unstructured":"Rajagopalan V, Pioro EP (2021) Corticospinal tract and related grey matter morphometric shape analysis in ALS phenotypes: a fractal dimension study. Brain Sci 2021:11","DOI":"10.3390\/brainsci11030371"},{"key":"12455_CR37","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1093\/cercor\/bhr002","volume":"21","author":"F Agosta","year":"2011","unstructured":"Agosta F, Valsasina P, Absinta M, Riva N, Sala S, Prelle A, Copetti M, Comola M, Comi G, Filippi M (2011) Sensorimotor functional connectivity changes in amyotrophic lateral sclerosis. Cereb Cortex 21:2291\u20132298","journal-title":"Cereb Cortex"},{"key":"12455_CR38","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.neurobiolaging.2013.09.041","volume":"35","author":"F Agosta","year":"2014","unstructured":"Agosta F, Canu E, Inuggi A, Chio A, Riva N, Silani V, Calvo A, Messina S, Falini A, Comi G, Filippi M (2014) Resting state functional connectivity alterations in primary lateral sclerosis. Neurobiol Aging 35:916\u2013925","journal-title":"Neurobiol Aging"},{"key":"12455_CR39","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00259-018-4246-2","volume":"46","author":"A Sala","year":"2019","unstructured":"Sala A, Iaccarino L, Fania P, Vanoli EG, Fallanca F, Pagnini C, Cerami C, Calvo A, Canosa A, Pagani M, Chio A, Cistaro A, Perani D (2019) Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis. Eur J Nucl Med Mol Imaging 46:1117\u20131131","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"12455_CR40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archneur.1986.00520040026013","volume":"43","author":"JK Matheson","year":"1986","unstructured":"Matheson JK, Harrington HJ, Hallett M (1986) Abnormalities of multimodality evoked potentials in amyotrophic lateral sclerosis. Arch Neurol 43:338\u2013340","journal-title":"Arch Neurol"},{"key":"12455_CR41","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0013-4694(85)90004-5","volume":"60","author":"RM Dasheiff","year":"1985","unstructured":"Dasheiff RM, Drake ME, Brendle A, Erwin CW (1985) Abnormal somatosensory evoked potentials in amyotrophic lateral sclerosis. Electroencephalogr Clin Neurophysiol 60:306\u2013311","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"12455_CR42","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/mus.880080703","volume":"8","author":"EP Bosch","year":"1985","unstructured":"Bosch EP, Yamada T, Kimura J (1985) Somatosensory evoked potentials in motor neuron disease. Muscle Nerve 8:556\u2013562","journal-title":"Muscle Nerve"},{"key":"12455_CR43","first-page":"273","volume":"31","author":"A Constantinovici","year":"1993","unstructured":"Constantinovici A (1993) Abnormal somatosensory evoked potentials in amyotrophic lateral sclerosis. Rom J Neurol Psychiatry 31:273\u2013278","journal-title":"Rom J Neurol Psychiatry"},{"key":"12455_CR44","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1212\/WNL.36.6.796","volume":"36","author":"RA Radtke","year":"1986","unstructured":"Radtke RA, Erwin A, Erwin CW (1986) Abnormal sensory evoked potentials in amyotrophic lateral sclerosis. Neurology 36:796\u2013801","journal-title":"Neurology"},{"key":"12455_CR45","first-page":"242","volume":"92","author":"K Ogata","year":"2001","unstructured":"Ogata K, Tobimatsu S, Furuya H, Kira J (2001) Sporadic amyotrophic lateral sclerosis showing abnormal somatosensory evoked potentials: a report of three cases. Fukuoka Igaku Zasshi 92:242\u2013250","journal-title":"Fukuoka Igaku Zasshi"},{"key":"12455_CR46","doi-asserted-by":"crossref","first-page":"e1578","DOI":"10.1212\/WNL.0000000000005424","volume":"90","author":"T Shimizu","year":"2018","unstructured":"Shimizu T, Bokuda K, Kimura H, Kamiyama T, Nakayama Y, Kawata A, Isozaki E, Ugawa Y (2018) Sensory cortex hyperexcitability predicts short survival in amyotrophic lateral sclerosis. Neurology 90:e1578\u2013e1587","journal-title":"Neurology"},{"key":"12455_CR47","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/21678421.2019.1704015","volume":"21","author":"T Shimizu","year":"2020","unstructured":"Shimizu T, Nakayama Y, Funai A, Morishima R, Hayashi K, Bokuda K, Nakata Y, Isozaki E (2020) Progressive deterioration of sensory cortex excitability in advanced amyotrophic lateral sclerosis with invasive ventilation. Amyotroph Lateral Scler Frontotemporal Degener 21:147\u2013149","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR48","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.clinph.2021.01.013","volume":"132","author":"M Khalili-Ardali","year":"2021","unstructured":"Khalili-Ardali M, Wu S, Tonin A, Birbaumer N, Chaudhary U (2021) Neurophysiological aspects of the completely locked-in syndrome in patients with advanced amyotrophic lateral sclerosis. Clin Neurophysiol 132:1064\u20131076","journal-title":"Clin Neurophysiol"},{"key":"12455_CR49","doi-asserted-by":"crossref","first-page":"e007659","DOI":"10.1136\/bmjopen-2015-007659","volume":"5","author":"C Iglesias","year":"2015","unstructured":"Iglesias C, Sangari S, El Mendili MM, Benali H, Marchand-Pauvert V, Pradat PF (2015) Electrophysiological and spinal imaging evidences for sensory dysfunction in amyotrophic lateral sclerosis. BMJ Open 5:e007659","journal-title":"BMJ Open"},{"key":"12455_CR50","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3109\/17482968.2012.701308","volume":"14","author":"J Cohen-Adad","year":"2013","unstructured":"Cohen-Adad J, El Mendili MM, Morizot-Koutlidis R, Lehericy S, Meininger V, Blancho S, Rossignol S, Benali H, Pradat PF (2013) Involvement of spinal sensory pathway in ALS and specificity of cord atrophy to lower motor neuron degeneration. Amyotroph Lateral Scler Frontotemporal Degener 14:30\u201338","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR51","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1212\/01.wnl.0000286948.99150.16","volume":"69","author":"M Hammad","year":"2007","unstructured":"Hammad M, Silva A, Glass J, Sladky JT, Benatar M (2007) Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology 69:2236\u20132242","journal-title":"Neurology"},{"key":"12455_CR52","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1007\/s00415-021-10835-9","volume":"269","author":"F Schoeberl","year":"2022","unstructured":"Schoeberl F, Abicht A, Kuepper C, Voelk S, Sonnenfeld S, Tonon M, Schaub A, Scholz V, Kleinle S, Erdmann H, Wolf DA, Reilich P (2022) Sensory neuropathy due to RFC1 in a patient with ALS: More than a coincidence? J Neurol 269:2774\u20132777","journal-title":"J Neurol"},{"key":"12455_CR53","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3858\/emm.2009.41.3.017","volume":"41","author":"YS Guo","year":"2009","unstructured":"Guo YS, Wu DX, Wu HR, Wu SY, Yang C, Li B, Bu H, Zhang YS, Li CY (2009) Sensory involvement in the SOD1-G93A mouse model of amyotrophic lateral sclerosis. Exp Mol Med 41:140\u2013150","journal-title":"Exp Mol Med"},{"key":"12455_CR54","doi-asserted-by":"crossref","first-page":"852163","DOI":"10.1155\/2014\/852163","volume":"2014","author":"J Sabado","year":"2014","unstructured":"Sabado J, Casanovas A, Tarabal O, Hereu M, Piedrafita L, Caldero J, Esquerda JE (2014) Accumulation of misfolded SOD1 in dorsal root ganglion degenerating proprioceptive sensory neurons of transgenic mice with amyotrophic lateral sclerosis. Biomed Res Int 2014:852163","journal-title":"Biomed Res Int"},{"key":"12455_CR55","doi-asserted-by":"crossref","first-page":"7600","DOI":"10.1038\/s41598-022-11767-8","volume":"12","author":"MA Rubio","year":"2022","unstructured":"Rubio MA, Herrando-Grabulosa M, Gaja-Capdevila N, Vilches JJ, Navarro X (2022) Characterization of somatosensory neuron involvement in the SOD1(G93A) mouse model. Sci Rep 12:7600","journal-title":"Sci Rep"},{"key":"12455_CR56","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/jnnp.2006.098533","volume":"78","author":"K Pugdahl","year":"2007","unstructured":"Pugdahl K, Fuglsang-Frederiksen A, de Carvalho M, Johnsen B, Fawcett PR, Labarre-Vila A, Liguori R, Nix WA, Schofield IS (2007) Generalised sensory system abnormalities in amyotrophic lateral sclerosis: a European multicentre study. J Neurol Neurosurg Psychiatry 78:746\u2013749","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR57","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s004150050379","volume":"246","author":"PA Theys","year":"1999","unstructured":"Theys PA, Peeters E, Robberecht W (1999) Evolution of motor and sensory deficits in amyotrophic lateral sclerosis estimated by neurophysiological techniques. J Neurol 246:438\u2013442","journal-title":"J Neurol"},{"key":"12455_CR58","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00838169","volume":"240","author":"R Gregory","year":"1993","unstructured":"Gregory R, Mills K, Donaghy M (1993) Progressive sensory nerve dysfunction in amyotrophic lateral sclerosis: a prospective clinical and neurophysiological study. J Neurol 240:309\u2013314","journal-title":"J Neurol"},{"key":"12455_CR59","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000505777","volume":"82","author":"A Pegat","year":"2019","unstructured":"Pegat A, Bouhour F, Mouzat K, Vial C, Pegat B, Leblanc P, Broussolle E, Millecamps S, Lumbroso S, Bernard E (2019) Electrophysiological characterization of C9ORF72-associated amyotrophic lateral sclerosis: a retrospective study. Eur Neurol 82:106\u2013112","journal-title":"Eur Neurol"},{"key":"12455_CR60","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.clinph.2008.01.010","volume":"119","author":"K Pugdahl","year":"2008","unstructured":"Pugdahl K, Fuglsang-Frederiksen A, Johnsen B, de Carvalho M, Fawcett PR, Labarre-Vila A, Liguori R, Nix WA, Schofield IS (2008) A prospective multicentre study on sural nerve action potentials in ALS. Clin Neurophysiol 119:1106\u20131110","journal-title":"Clin Neurophysiol"},{"key":"12455_CR61","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/mus.25157","volume":"54","author":"B Isak","year":"2016","unstructured":"Isak B, Tankisi H, Johnsen B, Pugdahl K, Torvin MA, Finnerup NB, Christensen PB, Fuglsang-Frederiksen A (2016) Involvement of distal sensory nerves in amyotrophic lateral sclerosis. Muscle Nerve 54:1086\u20131092","journal-title":"Muscle Nerve"},{"key":"12455_CR62","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s10072-011-0909-5","volume":"33","author":"M Luigetti","year":"2012","unstructured":"Luigetti M, Conte A, Del Grande A, Bisogni G, Romano A, Sabatelli M (2012) Sural nerve pathology in ALS patients: a single-centre experience. Neurol Sci 33:1095\u20131099","journal-title":"Neurol Sci"},{"key":"12455_CR63","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/WNL.0b013e31821e553a","volume":"76","author":"J Weis","year":"2011","unstructured":"Weis J, Katona I, Muller-Newen G, Sommer C, Necula G, Hendrich C, Ludolph AC, Sperfeld AD (2011) Small-fiber neuropathy in patients with ALS. Neurology 76:2024\u20132029","journal-title":"Neurology"},{"key":"12455_CR64","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jns.2017.01.005","volume":"373","author":"B Isak","year":"2017","unstructured":"Isak B, Pugdahl K, Karlsson P, Tankisi H, Finnerup NB, Furtula J, Johnsen B, Sunde N, Jakobsen J, Fuglsang-Frederiksen A (2017) Quantitative sensory testing and structural assessment of sensory nerve fibres in amyotrophic lateral sclerosis. J Neurol Sci 373:329\u2013334","journal-title":"J Neurol Sci"},{"key":"12455_CR65","doi-asserted-by":"crossref","unstructured":"Bombaci A, Lupica A, Pozzi FE, Remoli G, Manera U, Di Stefano V (2023) Sensory neuropathy in amyotrophic lateral sclerosis: a systematic review. J Neurol 2023:1","DOI":"10.1007\/s00415-023-11954-1"},{"key":"12455_CR66","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/0269216315600332","volume":"30","author":"X Moisset","year":"2016","unstructured":"Moisset X, Cornut-Chauvinc C, Clavelou P, Pereira B, Dallel R, Guy N (2016) Is there pain with neuropathic characteristics in patients with amyotrophic lateral sclerosis? A cross-sectional study. Palliat Med 30:486\u2013494","journal-title":"Palliat Med"},{"key":"12455_CR67","first-page":"5537892","volume":"2021","author":"R An","year":"2021","unstructured":"An R, Li Y, He X, Li C, Li X, Xu Y, He C (2021) The evaluation of pain with nociceptive and neuropathic characteristics from three different perspectives in amyotrophic lateral sclerosis patients: a case controlled observational study in southwestern China. Neural Plast 2021:5537892","journal-title":"Neural Plast"},{"key":"12455_CR68","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ejp.1091","volume":"22","author":"LCG Lopes","year":"2018","unstructured":"Lopes LCG, Galhardoni R, Silva V, Jorge FMH, Yeng LT, Callegaro D, Chadi G, Teixeira MJ, Ciampi de Andrade D (2018) Beyond weakness: Characterization of pain, sensory profile and conditioned pain modulation in patients with motor neuron disease: A controlled study. Eur J Pain 22:72\u201383","journal-title":"Eur J Pain"},{"key":"12455_CR69","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","volume":"155","author":"O van Hecke","year":"2014","unstructured":"van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N (2014) Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain 155:654\u2013662","journal-title":"Pain"},{"key":"12455_CR70","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/mus.20341","volume":"32","author":"TM Miller","year":"2005","unstructured":"Miller TM, Layzer RB (2005) Muscle cramps. Muscle Nerve 32:431\u2013442","journal-title":"Muscle Nerve"},{"key":"12455_CR71","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/mus.24892","volume":"53","author":"JB Caress","year":"2016","unstructured":"Caress JB, Ciarlone SL, Sullivan EA, Griffin LP, Cartwright MS (2016) Natural history of muscle cramps in amyotrophic lateral sclerosis. Muscle Nerve 53:513\u2013517","journal-title":"Muscle Nerve"},{"key":"12455_CR72","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/B978-0-444-52137-8.00012-7","volume":"109","author":"V Dietz","year":"2012","unstructured":"Dietz V, Sinkjaer T (2012) Spasticity. Handb Clin Neurol 109:197\u2013211","journal-title":"Handb Clin Neurol"},{"key":"12455_CR73","first-page":"S1","volume":"6","author":"NH Mayer","year":"1997","unstructured":"Mayer NH (1997) Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion. Muscle Nerve Suppl 6:S1-13","journal-title":"Muscle Nerve Suppl"},{"key":"12455_CR74","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.neurol.2020.08.009","volume":"177","author":"A Verschueren","year":"2021","unstructured":"Verschueren A, Grapperon AM, Delmont E, Attarian S (2021) Prevalence of spasticity and spasticity-related pain among patients with Amyotrophic Lateral Sclerosis. Rev Neurol (Paris) 177:694\u2013698","journal-title":"Rev Neurol (Paris)"},{"key":"12455_CR75","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/CND.0b013e31821c5623","volume":"13","author":"DT Ho","year":"2011","unstructured":"Ho DT, Ruthazer R, Russell JA (2011) Shoulder pain in amyotrophic lateral sclerosis. J Clin Neuromuscul Dis 13:53\u201355","journal-title":"J Clin Neuromuscul Dis"},{"key":"12455_CR76","first-page":"115","volume":"28","author":"A Pizzimenti","year":"2013","unstructured":"Pizzimenti A, Aragona M, Onesti E, Inghilleri M (2013) Depression, pain and quality of life in patients with amyotrophic lateral sclerosis: a cross-sectional study. Funct Neurol 28:115\u2013119","journal-title":"Funct Neurol"},{"key":"12455_CR77","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1080\/21678421.2021.1962354","volume":"23","author":"B Wigand","year":"2022","unstructured":"Wigand B, Schlichte I, Schreiber S, Heitmann J, Meyer T, Dengler R, Petri S, Haghikia A, Vielhaber S, Vogt S (2022) Characteristics of pain and the burden it causes in patients with amyotrophic lateral sclerosis - a longitudinal study. Amyotroph Lateral Scler Frontotemporal Degener 23:284\u2013291","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR78","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/01.WNL.0000125180.04000.A4","volume":"62","author":"EE Adelman","year":"2004","unstructured":"Adelman EE, Albert SM, Rabkin JG, Del Bene ML, Tider T, O\u2019Sullivan I (2004) Disparities in perceptions of distress and burden in ALS patients and family caregivers. Neurology 62:1766\u20131770","journal-title":"Neurology"},{"key":"12455_CR79","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3109\/21678421.2015.1131831","volume":"17","author":"D Raheja","year":"2016","unstructured":"Raheja D, Stephens HE, Lehman E, Walsh S, Yang C, Simmons Z (2016) Patient-reported problematic symptoms in an ALS treatment trial. Amyotroph Lateral Scler Frontotemporal Degener 17:198\u2013205","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR80","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1212\/WNL.52.7.1434","volume":"52","author":"L Ganzini","year":"1999","unstructured":"Ganzini L, Johnston WS, Hoffman WF (1999) Correlates of suffering in amyotrophic lateral sclerosis. Neurology 52:1434\u20131440","journal-title":"Neurology"},{"key":"12455_CR81","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/21678421.2012.751614","volume":"14","author":"I Rivera","year":"2013","unstructured":"Rivera I, Ajroud-Driss S, Casey P, Heller S, Allen J, Siddique T, Sufit R (2013) Prevalence and characteristics of pain in early and late stages of ALS. Amyotroph Lateral Scler Frontotemporal Degener 14:369\u2013372","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR82","first-page":"s261","volume":"19","author":"S Nalamachu","year":"2013","unstructured":"Nalamachu S (2013) An overview of pain management: the clinical efficacy and value of treatment. Am J Manag Care 19:s261-266","journal-title":"Am J Manag Care"},{"key":"12455_CR83","doi-asserted-by":"crossref","unstructured":"Ng L, Khan F, Young CA, Galea M (2017) Symptomatic treatments for amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database Syst Rev 1:CD011776","DOI":"10.1002\/14651858.CD011776.pub2"},{"key":"12455_CR84","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s42466-023-00251-x","volume":"5","author":"S Petri","year":"2023","unstructured":"Petri S, Grehl T, Grosskreutz J, Hecht M, Hermann A, Jesse S, Lingor P, Loscher W, Maier A, Schoser B, Weber M, Ludolph AC (2023) Guideline \u201cMotor neuron diseases\u201d of the German Society of Neurology (Deutsche Gesellschaft fur Neurologie). Neurol Res Pract 5:25","journal-title":"Neurol Res Pract"},{"key":"12455_CR85","doi-asserted-by":"crossref","unstructured":"Van Damme P, Al-Chalabi A, Andersen PM, Chio A, Couratier P, De Carvalho M, Hardiman O, Kuzma-Kozakiewicz M, Ludolph A, McDermott CJ, Mora JS, Petri S, Probyn K, Reviers E, Salachas F, Silani V, Tysnes OB, van den Berg LH, Villanueva G, Weber M (2024) European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERN EURO-NMD). Eur J Neurol:e16264","DOI":"10.1111\/ene.16264"},{"key":"12455_CR86","doi-asserted-by":"crossref","first-page":"175628561773473","DOI":"10.1177\/1756285617734734","volume":"11","author":"J Dorst","year":"2018","unstructured":"Dorst J, Ludolph AC, Huebers A (2018) Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis. Ther Adv Neurol Disord 11:1756285617734734","journal-title":"Ther Adv Neurol Disord"},{"key":"12455_CR87","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-510X(01)00622-0","volume":"191","author":"A Chio","year":"2001","unstructured":"Chio A, Silani V, Italian ALSSG (2001) Amyotrophic lateral sclerosis care in Italy: a nationwide study in neurological centers. J Neurol Sci 191:145\u2013150","journal-title":"J Neurol Sci"},{"key":"12455_CR88","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/146608201753275517","volume":"2","author":"GD Borasio","year":"2001","unstructured":"Borasio GD, Shaw PJ, Hardiman O, Ludolph AC, Sales Luis ML, Silani V, European ALSSG (2001) Standards of palliative care for patients with amyotrophic lateral sclerosis: results of a European survey. Amyotroph Lateral Scler Other Motor Neuron Disord 2:159\u2013164","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"12455_CR89","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/104990910402100206","volume":"21","author":"D Amtmann","year":"2004","unstructured":"Amtmann D, Weydt P, Johnson KL, Jensen MP, Carter GT (2004) Survey of cannabis use in patients with amyotrophic lateral sclerosis. Am J Hosp Palliat Care 21:95\u2013104","journal-title":"Am J Hosp Palliat Care"},{"key":"12455_CR90","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1049909110369531","volume":"27","author":"GT Carter","year":"2010","unstructured":"Carter GT, Abood ME, Aggarwal SK, Weiss MD (2010) Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials. Am J Hosp Palliat Care 27:347\u2013356","journal-title":"Am J Hosp Palliat Care"},{"key":"12455_CR91","doi-asserted-by":"crossref","first-page":"e029449","DOI":"10.1136\/bmjopen-2019-029449","volume":"9","author":"B Urbi","year":"2019","unstructured":"Urbi B, Broadley S, Bedlack R, Russo E, Sabet A (2019) Study protocol for a randomised, double-blind, placebo-controlled study evaluating the Efficacy of cannabis-based Medicine Extract in slowing the disease pRogression of Amyotrophic Lateral sclerosis or motor neurone Disease: the EMERALD trial. BMJ Open 9:e029449","journal-title":"BMJ Open"},{"key":"12455_CR92","doi-asserted-by":"crossref","unstructured":"El-Tawil S, Al Musa T, Valli H, Lunn MP, El-Tawil T, Weber M (2010) Quinine for muscle cramps. Cochrane Database Syst Rev:CD005044","DOI":"10.1002\/14651858.CD005044.pub2"},{"key":"12455_CR93","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1503\/cmaj.150044","volume":"187","author":"DB Hogan","year":"2015","unstructured":"Hogan DB (2015) Quinine: not a safe drug for treating nocturnal leg cramps. CMAJ 187:237\u2013238","journal-title":"CMAJ"},{"key":"12455_CR94","doi-asserted-by":"crossref","unstructured":"Oskarsson B, Moore D, Mozaffar T, Ravits J, Wiedau-Pazos M, Parziale N, Joyce NC, Mandeville R, Goyal N, Cudkowicz ME, Weiss M, Miller RG, McDonald CM (2018) Mexiletine for muscle cramps in amyotrophic lateral sclerosis: a randomized, double-blind crossover trial. Muscle Nerve 2018:1","DOI":"10.1002\/mus.26117"},{"key":"12455_CR95","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/mus.27146","volume":"63","author":"MD Weiss","year":"2021","unstructured":"Weiss MD, Macklin EA, McIlduff CE, Vucic S, Wainger BJ, Kiernan MC, Goutman SA, Goyal NA, Rutkove SB, Ladha SS, Chen IA, Harms MB, Brannagan TH, Lacomis D, Zivkovic S, Ma M, Wang LH, Simmons Z, Rivner MH, Shefner JM, Cudkowicz ME, Atassi N, Mexiletine ALSSG (2021) Effects of mexiletine on hyperexcitability in sporadic amyotrophic lateral sclerosis: preliminary findings from a small phase II randomized controlled trial. Muscle Nerve 63:371\u2013383","journal-title":"Muscle Nerve"},{"key":"12455_CR96","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/mus.26372","volume":"59","author":"S Lorusso","year":"2019","unstructured":"Lorusso S, Kline D, Bartlett A, Freimer M, Agriesti J, Hawash AA, Rich MM, Kissel JT, David Arnold W (2019) Open-label trial of ranolazine for the treatment of paramyotonia congenita. Muscle Nerve 59:240\u2013243","journal-title":"Muscle Nerve"},{"key":"12455_CR97","doi-asserted-by":"crossref","unstructured":"Baldinger R, Katzberg HD, Weber M (2012) Treatment for cramps in amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Datab Syst Rev 2012:CD004157","DOI":"10.1002\/14651858.CD004157.pub2"},{"key":"12455_CR98","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1186\/s13063-023-07424-8","volume":"24","author":"H Mitsumoto","year":"2023","unstructured":"Mitsumoto H, Cheung K, Oskarsson B, Andrews HF, Jang GE, Andrews JA, Shah JS, Fernandes JA, McElhiney M, Santella RM (2023) Randomized double-blind personalized N-of-1 clinical trial to test the safety and potential efficacy of TJ-68 for treating muscle cramps in amyotrophic lateral sclerosis (ALS): study protocol for a TJ-68 trial. Trials 24:449","journal-title":"Trials"},{"key":"12455_CR99","doi-asserted-by":"crossref","unstructured":"Riva N, Mora G, Soraru G, Lunetta C, Ferraro OE, Falzone Y, Leocani L, Fazio R, Comola M, Comi G, Group CS (2019) Safety and efficacy of nabiximols on spasticity symptoms in patients with motor neuron disease (CANALS): a multicentre, double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol 18:155\u2013164","DOI":"10.1016\/S1474-4422(18)30406-X"},{"key":"12455_CR100","doi-asserted-by":"crossref","unstructured":"Marvulli R, Megna M, Citraro A, Vacca E, Napolitano M, Gallo G, Fiore P, Ianieri G (2019) Botulinum toxin type a and physiotherapy in spasticity of the lower limbs due to amyotrophic lateral sclerosis. Toxins (Basel) 2019:11","DOI":"10.3390\/toxins11070381"},{"key":"12455_CR101","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00131402-200309000-00004","volume":"5","author":"LS Krivickas","year":"2003","unstructured":"Krivickas LS (2003) Exercise in neuromuscular disease. J Clin Neuromuscul Dis 5:29\u201339","journal-title":"J Clin Neuromuscul Dis"},{"key":"12455_CR102","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nrneurol.2014.184","volume":"10","author":"B Swinnen","year":"2014","unstructured":"Swinnen B, Robberecht W (2014) The phenotypic variability of amyotrophic lateral sclerosis. Nat Rev Neurol 10:661\u2013670","journal-title":"Nat Rev Neurol"},{"key":"12455_CR103","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/00019052-199612000-00011","volume":"9","author":"LB Krupp","year":"1996","unstructured":"Krupp LB, Pollina DA (1996) Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol 9:456\u2013460","journal-title":"Curr Opin Neurol"},{"key":"12455_CR104","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000445347","volume":"75","author":"IS Merkies","year":"2016","unstructured":"Merkies IS, Kieseier BC (2016) Fatigue, pain, anxiety and depression in guillain-barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. Eur Neurol 75:199\u2013206","journal-title":"Eur Neurol"},{"key":"12455_CR105","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00018-009-0184-2","volume":"67","author":"JM de Vries","year":"2010","unstructured":"de Vries JM, Hagemans ML, Bussmann JB, van der Ploeg AT, van Doorn PA (2010) Fatigue in neuromuscular disorders: focus on Guillain\u2013Barre syndrome and Pompe disease. Cell Mol Life Sci 67:701\u2013713","journal-title":"Cell Mol Life Sci"},{"key":"12455_CR106","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1136\/jnnp-2018-320050","volume":"90","author":"ZM Manjaly","year":"2019","unstructured":"Manjaly ZM, Harrison NA, Critchley HD, Do CT, Stefanics G, Wenderoth N, Lutterotti A, Muller A, Stephan KE (2019) Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis. J Neurol Neurosurg Psychiatry 90:642\u2013651","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR107","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000363763","volume":"72","author":"M Acciarresi","year":"2014","unstructured":"Acciarresi M, Bogousslavsky J, Paciaroni M (2014) Post-stroke fatigue: epidemiology, clinical characteristics and treatment. Eur Neurol 72:255\u2013261","journal-title":"Eur Neurol"},{"key":"12455_CR108","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1002\/mds.27461","volume":"33","author":"M Siciliano","year":"2018","unstructured":"Siciliano M, Trojano L, Santangelo G, De Micco R, Tedeschi G, Tessitore A (2018) Fatigue in Parkinson\u2019s disease: a systematic review and meta-analysis. Mov Disord 33:1712\u20131723","journal-title":"Mov Disord"},{"key":"12455_CR109","doi-asserted-by":"crossref","first-page":"101435","DOI":"10.1016\/j.berh.2019.101435","volume":"33","author":"O Seifert","year":"2019","unstructured":"Seifert O, Baerwald C (2019) Impact of fatigue on rheumatic diseases. Best Pract Res Clin Rheumatol 33:101435","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"12455_CR110","first-page":"248","volume":"7","author":"M Jiang","year":"2020","unstructured":"Jiang M, Ma Y, Yun B, Wang Q, Huang C, Han L (2020) Exercise for fatigue in breast cancer patients: an umbrella review of systematic reviews. Int J Nurs Sci 7:248\u2013254","journal-title":"Int J Nurs Sci"},{"key":"12455_CR111","doi-asserted-by":"crossref","unstructured":"Vis R, van de Garde EMW, Grutters JC, Korenromp IHE (2020) The effects of pharmacological interventions on quality of life and fatigue in sarcoidosis: a systematic review. Eur Respir Rev 2020:29","DOI":"10.1183\/16000617.0057-2019"},{"key":"12455_CR112","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/bjd.15375","volume":"177","author":"IM Skoie","year":"2017","unstructured":"Skoie IM, Dalen I, Ternowitz T, Jonsson G, Kvivik I, Norheim K, Omdal R (2017) Fatigue in psoriasis: a controlled study. Br J Dermatol 177:505\u2013512","journal-title":"Br J Dermatol"},{"key":"12455_CR113","first-page":"e42","volume":"178","author":"PT Riis","year":"2018","unstructured":"Riis PT, Sigsgaard V, Boer J, Jemec GBE (2018) A pilot study of fatigue in patients with hidradenitis suppurativa. Br J Dermatol 178:e42\u2013e43","journal-title":"Br J Dermatol"},{"key":"12455_CR114","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/mus.27076","volume":"62","author":"SZ Peric","year":"2020","unstructured":"Peric SZ, Cornblath DR (2020) Fatigue in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 62:649\u2013651","journal-title":"Muscle Nerve"},{"key":"12455_CR115","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1590\/0004-282x-anp-2021-0201","volume":"80","author":"MA Alencar","year":"2022","unstructured":"Alencar MA, Soares BL, Rangel MFA, Abdo JS, Almeida RAP, Araujo CM, Souza LC, Gomes GC (2022) Fatigue in amyotrophic lateral sclerosis and correlated factors. Arq Neuropsiquiatr 80:1045\u20131051","journal-title":"Arq Neuropsiquiatr"},{"key":"12455_CR116","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jns.2016.09.034","volume":"370","author":"P Sandstedt","year":"2016","unstructured":"Sandstedt P, Johansson S, Ytterberg C, Ingre C, Holmqvist LW, Kierkegaard M (2016) Predictors of health-related quality of life in people with amyotrophic lateral sclerosis. J Neurol Sci 370:269\u2013273","journal-title":"J Neurol Sci"},{"key":"12455_CR117","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jpainsymman.2020.02.021","volume":"60","author":"S Vogt","year":"2020","unstructured":"Vogt S, Schreiber S, Pfau G, Kollewe K, Heinze HJ, Dengler R, Petri S, Vielhaber S, Brinkers M (2020) Dyspnea as a fatigue-promoting factor in als and the role of objective indicators of respiratory impairment. J Pain Symptom Manag 60:430-438 e431","journal-title":"J Pain Symptom Manag"},{"issue":"Suppl 3","key":"12455_CR118","doi-asserted-by":"crossref","first-page":"S198","DOI":"10.1016\/j.nmd.2012.10.013","volume":"22","author":"A Abraham","year":"2012","unstructured":"Abraham A, Drory VE (2012) Fatigue in motor neuron diseases. Neuromuscul Disord 22(Suppl 3):S198-202","journal-title":"Neuromuscul Disord"},{"key":"12455_CR119","doi-asserted-by":"crossref","unstructured":"Hamad AA, Amer BE, Abbas NB, Alnajjar AZ, Meshref M (2023) Prevalence and correlates of fatigue in amyotrophic lateral sclerosis: a systematic review and meta-analysis. Neurol Sci 2023:1","DOI":"10.1007\/s10072-023-07119-7"},{"key":"12455_CR120","doi-asserted-by":"crossref","first-page":"806577","DOI":"10.3389\/fneur.2022.806577","volume":"13","author":"R An","year":"2022","unstructured":"An R, Li C, Li X, Wu Y, He X, Ai S, Xu Y, He C (2022) Fatigue in Chinese patients with amyotrophic lateral sclerosis: associated factors and impact on quality of life. Front Neurol 13:806577","journal-title":"Front Neurol"},{"key":"12455_CR121","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1468-1331.2011.03637.x","volume":"19","author":"D Lo Coco","year":"2012","unstructured":"Lo Coco D, La Bella V (2012) Fatigue, sleep, and nocturnal complaints in patients with amyotrophic lateral sclerosis. Eur J Neurol 19:760\u2013763","journal-title":"Eur J Neurol"},{"key":"12455_CR122","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/jnnp.2008.163246","volume":"80","author":"MC McElhiney","year":"2009","unstructured":"McElhiney MC, Rabkin JG, Gordon PH, Goetz R, Mitsumoto H (2009) Prevalence of fatigue and depression in ALS patients and change over time. J Neurol Neurosurg Psychiatry 80:1146\u20131149","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR123","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/ane.12349","volume":"131","author":"S Panitz","year":"2015","unstructured":"Panitz S, Kornhuber M, Hanisch F (2015) The checklist individual strength (CIS20-R) in patients with amyotrophic lateral sclerosis\u2014a longitudinal study. Acta Neurol Scand 131:372\u2013380","journal-title":"Acta Neurol Scand"},{"key":"12455_CR124","doi-asserted-by":"crossref","unstructured":"Gibbons C, Pagnini F, Friede T, Young CA (2018) Treatment of fatigue in amyotrophic lateral sclerosis\/motor neuron disease. Cochrane Database Syst Rev 1:CD011005","DOI":"10.1002\/14651858.CD011005.pub2"},{"key":"12455_CR125","doi-asserted-by":"crossref","unstructured":"Diagnosis ETFo, Management of Amyotrophic Lateral S, Andersen PM, Abrahams S, Borasio GD, de Carvalho M, Chio A, Van Damme P, Hardiman O, Kollewe K, Morrison KE, Petri S, Pradat PF, Silani V, Tomik B, Wasner M, Weber M (2012) EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)\u2014revised report of an EFNS task force. Eur J Neurol 19:360\u2013375","DOI":"10.1111\/j.1468-1331.2011.03501.x"},{"key":"12455_CR126","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1097\/00001756-199709080-00016","volume":"8","author":"L Ferraro","year":"1997","unstructured":"Ferraro L, Antonelli T, O\u2019Connor WT, Tanganelli S, Rambert F, Fuxe K (1997) The antinarcoleptic drug modafinil increases glutamate release in thalamic areas and hippocampus. NeuroReport 8:2883\u20132887","journal-title":"NeuroReport"},{"key":"12455_CR127","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0893-133X(98)00085-2","volume":"20","author":"L Ferraro","year":"1999","unstructured":"Ferraro L, Antonelli T, Tanganelli S, O\u2019Connor WT, Perez de la Mora M, Mendez-Franco J, Rambert FA, Fuxe K (1999) The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade. Neuropsychopharmacology 20:346\u2013356","journal-title":"Neuropsychopharmacology"},{"key":"12455_CR128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/104990910502200112","volume":"22","author":"GT Carter","year":"2005","unstructured":"Carter GT, Weiss MD, Lou JS, Jensen MP, Abresch RT, Martin TK, Hecht TW, Han JJ, Weydt P, Kraft GH (2005) Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study. Am J Hosp Palliat Care 22:55\u201359","journal-title":"Am J Hosp Palliat Care"},{"key":"12455_CR129","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/mus.21245","volume":"39","author":"JG Rabkin","year":"2009","unstructured":"Rabkin JG, Gordon PH, McElhiney M, Rabkin R, Chew S, Mitsumoto H (2009) Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study. Muscle Nerve 39:297\u2013303","journal-title":"Muscle Nerve"},{"key":"12455_CR130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1080\/17482960802028890","volume":"9","author":"J Rosenfeld","year":"2008","unstructured":"Rosenfeld J, King RM, Jackson CE, Bedlack RS, Barohn RJ, Dick A, Phillips LH, Chapin J, Gelinas DF, Lou JS (2008) Creatine monohydrate in ALS: effects on strength, fatigue, respiratory status and ALSFRS. Amyotroph Lateral Scler 9:266\u2013272","journal-title":"Amyotroph Lateral Scler"},{"key":"12455_CR131","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/CND.0b013e3182095b2b","volume":"12","author":"TE Bertorini","year":"2011","unstructured":"Bertorini TE, Rashed H, Zeno M, Tolley EA, Igarashi M, Li YD (2011) Effects of 3\u20134 diaminopyridine (DAP) in motor neuron diseases. J Clin Neuromuscul Dis 12:129\u2013137","journal-title":"J Clin Neuromuscul Dis"},{"key":"12455_CR132","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2165\/00007256-199825030-00004","volume":"25","author":"DG Behm","year":"1998","unstructured":"Behm DG, St-Pierre DM (1998) The effects of strength training and disuse on the mechanisms of fatigue. Sports Med 25:173\u2013189","journal-title":"Sports Med"},{"key":"12455_CR133","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.apmr.2010.08.009","volume":"91","author":"M Sanjak","year":"2010","unstructured":"Sanjak M, Bravver E, Bockenek WL, Norton HJ, Brooks BR (2010) Supported treadmill ambulation for amyotrophic lateral sclerosis: a pilot study. Arch Phys Med Rehabil 91:1920\u20131929","journal-title":"Arch Phys Med Rehabil"},{"key":"12455_CR134","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0022-510X(01)00610-4","volume":"191","author":"VE Drory","year":"2001","unstructured":"Drory VE, Goltsman E, Reznik JG, Mosek A, Korczyn AD (2001) The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 191:133\u2013137","journal-title":"J Neurol Sci"},{"key":"12455_CR135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jns.2008.01.011","volume":"270","author":"G Zanette","year":"2008","unstructured":"Zanette G, Forgione A, Manganotti P, Fiaschi A, Tamburin S (2008) The effect of repetitive transcranial magnetic stimulation on motor performance, fatigue and quality of life in amyotrophic lateral sclerosis. J Neurol Sci 270:18\u201322","journal-title":"J Neurol Sci"},{"key":"12455_CR136","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/21678421.2022.2053721","volume":"24","author":"MA Kutlubaev","year":"2023","unstructured":"Kutlubaev MA, Caga J, Xu Y, Areprintseva DK, Pervushina EV, Kiernan MC (2023) Apathy in amyotrophic lateral sclerosis: systematic review and meta-analysis of frequency, correlates, and outcomes. Amyotroph Lateral Scler Frontotemporal Degener 24:14\u201323","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR137","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/ene.15177","volume":"29","author":"D Weise","year":"2022","unstructured":"Weise D, Menze I, Metelmann MCF, Woost TB, Classen J, Otto Pelz J (2022) Multimodal assessment of autonomic dysfunction in amyotrophic lateral sclerosis. Eur J Neurol 29:715\u2013723","journal-title":"Eur J Neurol"},{"key":"12455_CR138","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/jon.12993","volume":"32","author":"M Papadopoulou","year":"2022","unstructured":"Papadopoulou M, Bakola E, Papapostolou A, Stefanou MI, Moschovos C, Salakou S, Zis P, Zouvelou V, Kimiskidis VK, Chroni E, Tsivgoulis G (2022) Autonomic dysfunction in amyotrophic lateral sclerosis: A neurophysiological and neurosonology study. J Neuroimaging 32:710\u2013719","journal-title":"J Neuroimaging"},{"key":"12455_CR139","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mus.24457","volume":"51","author":"EA Piccione","year":"2015","unstructured":"Piccione EA, Sletten DM, Staff NP, Low PA (2015) Autonomic system and amyotrophic lateral sclerosis. Muscle Nerve 51:676\u2013679","journal-title":"Muscle Nerve"},{"key":"12455_CR140","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jns.2014.07.022","volume":"345","author":"L McCluskey","year":"2014","unstructured":"McCluskey L, Vandriel S, Elman L, Van Deerlin VM, Powers J, Boller A, Wood EM, Woo J, McMillan CT, Rascovsky K, Grossman M (2014) ALS-Plus syndrome: non-pyramidal features in a large ALS cohort. J Neurol Sci 345:118\u2013124","journal-title":"J Neurol Sci"},{"key":"12455_CR141","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/21678421.2013.868001","volume":"15","author":"GS Nubling","year":"2014","unstructured":"Nubling GS, Mie E, Bauer RM, Hensler M, Lorenzl S, Hapfelmeier A, Irwin DE, Borasio GD, Winkler AS (2014) Increased prevalence of bladder and intestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 15:174\u2013179","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR142","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/01.wco.0000183114.76056.0e","volume":"18","author":"R Baltadzhieva","year":"2005","unstructured":"Baltadzhieva R, Gurevich T, Korczyn AD (2005) Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol 18:487\u2013493","journal-title":"Curr Opin Neurol"},{"key":"12455_CR143","doi-asserted-by":"crossref","first-page":"352","DOI":"10.3109\/17482968.2011.574141","volume":"12","author":"ML Lopes de Carvalho","year":"2011","unstructured":"Lopes de Carvalho ML, Motta R, Battaglia MA, Brichetto G (2011) Urinary disorders in amyotrophic lateral sclerosis subjects. Amyotroph Lateral Scler 12:352\u2013355","journal-title":"Amyotroph Lateral Scler"},{"key":"12455_CR144","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/nau.22976","volume":"36","author":"S Arlandis","year":"2017","unstructured":"Arlandis S, Vazquez-Costa JF, Martinez-Cuenca E, Sevilla T, Boronat F, Broseta E (2017) Urodynamic findings in amyotrophic lateral sclerosis patients with lower urinary tract symptoms: Results from a pilot study. Neurourol Urodyn 36:626\u2013631","journal-title":"Neurourol Urodyn"},{"key":"12455_CR145","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jns.2017.04.053","volume":"378","author":"JF Vazquez-Costa","year":"2017","unstructured":"Vazquez-Costa JF, Arlandis S, Hervas D, Martinez-Cuenca E, Cardona F, Perez-Tur J, Broseta E, Sevilla T (2017) Clinical profile of motor neuron disease patients with lower urinary tract symptoms and neurogenic bladder. J Neurol Sci 378:130\u2013136","journal-title":"J Neurol Sci"},{"key":"12455_CR146","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/mus.880180808","volume":"18","author":"M Carvalho","year":"1995","unstructured":"Carvalho M, Schwartz MS, Swash M (1995) Involvement of the external anal sphincter in amyotrophic lateral sclerosis. Muscle Nerve 18:848\u2013853","journal-title":"Muscle Nerve"},{"key":"12455_CR147","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0022-510X(86)90130-9","volume":"73","author":"H Konno","year":"1986","unstructured":"Konno H, Yamamoto T, Iwasaki Y, Iizuka H (1986) Shy-Drager syndrome and amyotrophic lateral sclerosis. Cytoarchitectonic and morphometric studies of sacral autonomic neurons. J Neurol Sci 73:193\u2013204","journal-title":"J Neurol Sci"},{"key":"12455_CR148","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0022-510X(96)05313-0","volume":"147","author":"T Kihira","year":"1997","unstructured":"Kihira T, Yoshida S, Yoshimasu F, Wakayama I, Yase Y (1997) Involvement of Onuf\u2019s nucleus in amyotrophic lateral sclerosis. J Neurol Sci 147:81\u201388","journal-title":"J Neurol Sci"},{"key":"12455_CR149","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S1474-4422(15)00070-8","volume":"14","author":"JN Panicker","year":"2015","unstructured":"Panicker JN, Fowler CJ, Kessler TM (2015) Lower urinary tract dysfunction in the neurological patient: clinical assessment and management. Lancet Neurol 14:720\u2013732","journal-title":"Lancet Neurol"},{"key":"12455_CR150","doi-asserted-by":"crossref","first-page":"117543","DOI":"10.1016\/j.jns.2021.117543","volume":"427","author":"VC Samara","year":"2021","unstructured":"Samara VC, Jerant P, Gibson S, Bromberg M (2021) Bowel, bladder, and sudomotor symptoms in ALS patients. J Neurol Sci 427:117543","journal-title":"J Neurol Sci"},{"key":"12455_CR151","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0022-510X(89)90158-5","volume":"93","author":"H Hayashi","year":"1989","unstructured":"Hayashi H, Kato S (1989) Total manifestations of amyotrophic lateral sclerosis. ALS in the totally locked-in state. J Neurol Sci 93:19\u201335","journal-title":"J Neurol Sci"},{"key":"12455_CR152","first-page":"473","volume":"2","author":"M Toepfer","year":"1997","unstructured":"Toepfer M, Schroeder M, Klauser A, Lochmuller H, Hirschmann M, Riepl RL, Pongratz D, Muller-Felber W (1997) Delayed colonic transit times in amyotrophic lateral sclerosis assessed with radio-opaque markers. Eur J Med Res 2:473\u2013476","journal-title":"Eur J Med Res"},{"key":"12455_CR153","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1750-1326-9-24","volume":"9","author":"S Herdewyn","year":"2014","unstructured":"Herdewyn S, Cirillo C, Van Den Bosch L, Robberecht W, Vanden Berghe P, Van Damme P (2014) Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T) mice. Mol Neurodegener 9:24","journal-title":"Mol Neurodegener"},{"key":"12455_CR154","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/mus.880181103","volume":"18","author":"F Pisano","year":"1995","unstructured":"Pisano F, Miscio G, Mazzuero G, Lanfranchi P, Colombo R, Pinelli P (1995) Decreased heart rate variability in amyotrophic lateral sclerosis. Muscle Nerve 18:1225\u20131231","journal-title":"Muscle Nerve"},{"key":"12455_CR155","first-page":"e14536","volume":"75","author":"D Iscan","year":"2021","unstructured":"Iscan D, Karaaslan MB, Deveci OS, Akilli Eker R, Koc F (2021) The importance of heart rate variability in predicting cardiac autonomic dysfunction in patients with amyotrophic lateral sclerosis. Int J Clin Pract 75:e14536","journal-title":"Int J Clin Pract"},{"key":"12455_CR156","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/17482960903390855","volume":"11","author":"S Pavlovic","year":"2010","unstructured":"Pavlovic S, Stevic Z, Milovanovic B, Milicic B, Rakocevic-Stojanovic V, Lavrnic D, Apostolski S (2010) Impairment of cardiac autonomic control in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11:272\u2013276","journal-title":"Amyotroph Lateral Scler"},{"key":"12455_CR157","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/mus.23313","volume":"46","author":"S Pinto","year":"2012","unstructured":"Pinto S, Pinto A, De Carvalho M (2012) Decreased heart rate variability predicts death in amyotrophic lateral sclerosis. Muscle Nerve 46:341\u2013345","journal-title":"Muscle Nerve"},{"key":"12455_CR158","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0022-510X(94)90009-4","volume":"124","author":"T Shimizu","year":"1994","unstructured":"Shimizu T, Hayashi H, Kato S, Hayashi M, Tanabe H, Oda M (1994) Circulatory collapse and sudden death in respirator-dependent amyotrophic lateral sclerosis. J Neurol Sci 124:45\u201355","journal-title":"J Neurol Sci"},{"key":"12455_CR159","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3389\/fneur.2017.00479","volume":"8","author":"A Rosenbohm","year":"2017","unstructured":"Rosenbohm A, Schmid B, Buckert D, Rottbauer W, Kassubek J, Ludolph AC, Bernhardt P (2017) Cardiac findings in amyotrophic lateral sclerosis: a magnetic resonance imaging study. Front Neurol 8:479","journal-title":"Front Neurol"},{"key":"12455_CR160","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1007\/s00415-013-7005-0","volume":"260","author":"Y Tanaka","year":"2013","unstructured":"Tanaka Y, Yamada M, Koumura A, Sakurai T, Hayashi Y, Kimura A, Hozumi I, Inuzuka T (2013) Cardiac sympathetic function in the patients with amyotrophic lateral sclerosis: analysis using cardiac [123I] MIBG scintigraphy. J Neurol 260:2380\u20132386","journal-title":"J Neurol"},{"key":"12455_CR161","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0006-8993(91)91680-Y","volume":"566","author":"O Bertel","year":"1991","unstructured":"Bertel O, Malessa S, Sluga E, Hornykiewicz O (1991) Amyotrophic lateral sclerosis: changes of noradrenergic and serotonergic transmitter systems in the spinal cord. Brain Res 566:54\u201360","journal-title":"Brain Res"},{"key":"12455_CR162","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S1566-0702(01)00217-X","volume":"88","author":"T Ohno","year":"2001","unstructured":"Ohno T, Shimizu T, Kato S, Hayashi H, Hirai S (2001) Effect of tamsulosin hydrochloride on sympathetic hyperactivity in amyotrophic lateral sclerosis. Auton Neurosci 88:94\u201398","journal-title":"Auton Neurosci"},{"key":"12455_CR163","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/BF02267978","volume":"7","author":"A Yamashita","year":"1997","unstructured":"Yamashita A, Koike Y, Takahashi A, Hirayama M, Murakami N, Sobue G (1997) Relationship between respiratory failure and plasma noradrenaline levels in amyotrophic lateral sclerosis. Clin Auton Res 7:173\u2013177","journal-title":"Clin Auton Res"},{"key":"12455_CR164","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1080\/14660820510028412","volume":"6","author":"M Beck","year":"2005","unstructured":"Beck M, Flachenecker P, Magnus T, Giess R, Reiners K, Toyka KV, Naumann M (2005) Autonomic dysfunction in ALS: a preliminary study on the effects of intrathecal BDNF. Amyotroph Lateral Scler Other Motor Neuron Disord 6:100\u2013103","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"12455_CR165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4103\/2152-7806.169561","volume":"6","author":"S Zarei","year":"2015","unstructured":"Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D, Orozco G, Chinea A (2015) A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int 6:171","journal-title":"Surg Neurol Int"},{"key":"12455_CR166","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/ene.12015","volume":"20","author":"S Korner","year":"2013","unstructured":"Korner S, Kollewe K, Ilsemann J, Muller-Heine A, Dengler R, Krampfl K, Petri S (2013) Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis. Eur J Neurol 20:647\u2013654","journal-title":"Eur J Neurol"},{"key":"12455_CR167","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1007\/s00103-013-1666-9","volume":"56","author":"A Gosswald","year":"2013","unstructured":"Gosswald A, Schienkiewitz A, Nowossadeck E, Busch MA (2013) Prevalence of myocardial infarction and coronary heart disease in adults aged 40\u201379 years in Germany: results of the German Health Interview and Examination Survey for Adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 56:650\u2013655","journal-title":"Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz"},{"key":"12455_CR168","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1136\/jnnp-2016-315071","volume":"88","author":"AE Visser","year":"2017","unstructured":"Visser AE, Seelen M, Hulsbergen A, de Graaf J, van der Kooi AJ, Raaphorst J, Veldink JH, van den Berg LH (2017) Exploring the fitness hypothesis in ALS: a population-based case-control study of parental cause of death and lifespan. J Neurol Neurosurg Psychiatry 88:550\u2013556","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR169","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1136\/jnnp-2011-301161","volume":"83","author":"MR Turner","year":"2012","unstructured":"Turner MR, Wotton C, Talbot K, Goldacre MJ (2012) Cardiovascular fitness as a risk factor for amyotrophic lateral sclerosis: indirect evidence from record linkage study. J Neurol Neurosurg Psychiatry 83:395\u2013398","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR170","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jocn.2021.12.021","volume":"96","author":"K Xu","year":"2022","unstructured":"Xu K, Ji H, Hu N (2022) Cardiovascular comorbidities in amyotrophic lateral sclerosis: a systematic review. J Clin Neurosci 96:43\u201349","journal-title":"J Clin Neurosci"},{"key":"12455_CR171","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/17482968.2011.610110","volume":"13","author":"C Moreau","year":"2012","unstructured":"Moreau C, Brunaud-Danel V, Dallongeville J, Duhamel A, Laurier-Grymonprez L, de Reuck J, Wiart AC, Perez T, Richard F, Amouyel P, Bordet R, Defebvre L, Destee A, Devos D (2012) Modifying effect of arterial hypertension on amyotrophic lateral sclerosis. Amyotroph Lateral Scler 13:194\u2013201","journal-title":"Amyotroph Lateral Scler"},{"key":"12455_CR172","doi-asserted-by":"crossref","first-page":"117292","DOI":"10.1016\/j.jns.2020.117292","volume":"421","author":"M Pereira","year":"2021","unstructured":"Pereira M, Gromicho M, Henriques A, Pronto-Laborinho AC, Grosskreutz J, Kuzma-Kozakiewicz M, Petri S, Uysal H, Swash M, de Carvalho M (2021) Cardiovascular comorbidities in amyotrophic lateral sclerosis. J Neurol Sci 421:117292","journal-title":"J Neurol Sci"},{"key":"12455_CR173","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/ene.13620","volume":"25","author":"J Mandrioli","year":"2018","unstructured":"Mandrioli J, Ferri L, Fasano A, Zucchi E, Fini N, Moglia C, Lunetta C, Marinou K, Ticozzi N, Drago Ferrante G, Scialo C, Soraru G, Trojsi F, Conte A, Falzone YM, Tortelli R, Russo M, Sansone VA, Mora G, Silani V, Volanti P, Caponnetto C, Querin G, Monsurro MR, Sabatelli M, Chio A, Riva N, Logroscino G, Messina S, Calvo A (2018) Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis. Eur J Neurol 25:861\u2013868","journal-title":"Eur J Neurol"},{"key":"12455_CR174","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp.2010.236752","volume":"82","author":"NA Sutedja","year":"2011","unstructured":"Sutedja NA, van der Schouw YT, Fischer K, Sizoo EM, Huisman MH, Veldink JH, Van den Berg LH (2011) Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82:638\u2013642","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR175","doi-asserted-by":"crossref","unstructured":"Pawlukowska W, Baumert B, Golab-Janowska M, Meller A, Machowska-Sempruch K, Welnicka A, Paczkowska E, Rotter I, Machalinski B, Nowacki P (2020) The relationship between selected demographic factors and speech organ dysfunction in sporadic ALS patients. Medicina (Kaunas) 2020:56","DOI":"10.21203\/rs.3.rs-19421\/v1"},{"key":"12455_CR176","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1016\/S0140-6736(17)32478-9","volume":"390","author":"J Lu","year":"2017","unstructured":"Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, Cheng X, Mu L, Zhang H, Liu J, Su M, Zhao H, Spatz ES, Spertus JA, Masoudi FA, Krumholz HM, Jiang L (2017) Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet 390:2549\u20132558","journal-title":"Lancet"},{"key":"12455_CR177","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1007\/s00415-020-09799-z","volume":"267","author":"K Diekmann","year":"2020","unstructured":"Diekmann K, Kuzma-Kozakiewicz M, Piotrkiewicz M, Gromicho M, Grosskreutz J, Andersen PM, de Carvalho M, Uysal H, Osmanovic A, Schreiber-Katz O, Petri S, Korner S (2020) Impact of comorbidities and co-medication on disease onset and progression in a large German ALS patient group. J Neurol 267:2130\u20132141","journal-title":"J Neurol"},{"key":"12455_CR178","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1001\/archneur.1991.00530150051017","volume":"48","author":"C Armon","year":"1991","unstructured":"Armon C, Kurland LT, O\u2019Brien PC, Mulder DW (1991) Antecedent medical diseases in patients with amyotrophic lateral sclerosis. A population-based case-controlled study in Rochester, Minn, 1925 through 1987. Arch Neurol 48:283\u2013286","journal-title":"Arch Neurol"},{"key":"12455_CR179","doi-asserted-by":"crossref","first-page":"e398","DOI":"10.1212\/NXG.0000000000000398","volume":"6","author":"BB Trabjerg","year":"2020","unstructured":"Trabjerg BB, Garton FC, van Rheenen W, Fang F, Henderson RD, Mortensen PB, Agerbo E, Wray NR (2020) ALS in Danish Registries: heritability and links to psychiatric and cardiovascular disorders. Neurol Genet 6:e398","journal-title":"Neurol Genet"},{"key":"12455_CR180","unstructured":"KIM K, Kim S, Katana M, Terentyev D, Radwa\u0144ski PB, Munger M (2023) Riluzole is Associated With Reduced Risk of Heart Failure. medRxiv:2023.2012.2028.23300552"},{"key":"12455_CR181","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1378\/chest.14-0970","volume":"146","author":"MJ Sateia","year":"2014","unstructured":"Sateia MJ (2014) International classification of sleep disorders-third edition: highlights and modifications. Chest 146:1387\u20131394","journal-title":"Chest"},{"key":"12455_CR182","doi-asserted-by":"crossref","first-page":"170","DOI":"10.3389\/fnagi.2017.00170","volume":"9","author":"S Hood","year":"2017","unstructured":"Hood S, Amir S (2017) Neurodegeneration and the circadian clock. Front Aging Neurosci 9:170","journal-title":"Front Aging Neurosci"},{"key":"12455_CR183","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.smrv.2015.05.007","volume":"26","author":"RM Ahmed","year":"2016","unstructured":"Ahmed RM, Newcombe RE, Piper AJ, Lewis SJ, Yee BJ, Kiernan MC, Grunstein RR (2016) Sleep disorders and respiratory function in amyotrophic lateral sclerosis. Sleep Med Rev 26:33\u201342","journal-title":"Sleep Med Rev"},{"key":"12455_CR184","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/21678421.2020.1844755","volume":"22","author":"D Lucia","year":"2021","unstructured":"Lucia D, McCombe PA, Henderson RD, Ngo ST (2021) Disorders of sleep and wakefulness in amyotrophic lateral sclerosis (ALS): a systematic review. Amyotroph Lateral Scler Frontotemporal Degener 22:161\u2013169","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR185","doi-asserted-by":"crossref","first-page":"700","DOI":"10.4103\/0028-3886.232327","volume":"66","author":"S Panda","year":"2018","unstructured":"Panda S, Gourie-Devi M, Sharma A (2018) Sleep disorders in amyotrophic lateral sclerosis: a questionnaire-based study from India. Neurol India 66:700\u2013708","journal-title":"Neurol India"},{"key":"12455_CR186","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/CND.0000000000000234","volume":"20","author":"M Diaz-Abad","year":"2018","unstructured":"Diaz-Abad M, Buczyner JR, Venza BR, Scharf SM, Kwan JY, Lubinski B, Russell JW (2018) Poor sleep quality in patients with amyotrophic lateral sclerosis at the time of diagnosis. J Clin Neuromuscul Dis 20:60\u201368","journal-title":"J Clin Neuromuscul Dis"},{"key":"12455_CR187","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/jnnp.2010.228007","volume":"82","author":"D Lo Coco","year":"2011","unstructured":"Lo Coco D, Mattaliano P, Spataro R, Mattaliano A, La Bella V (2011) Sleep-wake disturbances in patients with amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 82:839\u2013842","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR188","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1007\/s00415-021-10900-3","volume":"269","author":"S Liu","year":"2022","unstructured":"Liu S, Ren Q, Gong G, Sun Y, Zhao B, Ma X, Zhang N, Zhong S, Lin Y, Wang W, Zheng R, Yu X, Yun Y, Zhang D, Shao K, Lin P, Yuan Y, Dai T, Zhang Y, Li L, Li W, Zhao Y, Shan P, Meng X, Yan C (2022) Hypothalamic subregion abnormalities are related to body mass index in patients with sporadic amyotrophic lateral sclerosis. J Neurol 269:2980\u20132988","journal-title":"J Neurol"},{"key":"12455_CR189","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1136\/jnnp-2017-315795","volume":"88","author":"M Gorges","year":"2017","unstructured":"Gorges M, Vercruysse P, Muller HP, Huppertz HJ, Rosenbohm A, Nagel G, Weydt P, Petersen A, Ludolph AC, Kassubek J, Dupuis L (2017) Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 88:1033\u20131041","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR190","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nn1789","volume":"9","author":"PH Ozdinler","year":"2006","unstructured":"Ozdinler PH, Macklis JD (2006) IGF-I specifically enhances axon outgrowth of corticospinal motor neurons. Nat Neurosci 9:1371\u20131381","journal-title":"Nat Neurosci"},{"key":"12455_CR191","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12868-015-0140-z","volume":"16","author":"JY Chung","year":"2015","unstructured":"Chung JY, Kim HJ, Kim M (2015) The protective effect of growth hormone on Cu\/Zn superoxide dismutase-mutant motor neurons. BMC Neurosci 16:1","journal-title":"BMC Neurosci"},{"key":"12455_CR192","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/BF03346653","volume":"33","author":"M Gasperi","year":"2010","unstructured":"Gasperi M, Castellano AE (2010) Growth hormone\/insulin-like growth factor I axis in neurodegenerative diseases. J Endocrinol Invest 33:587\u2013591","journal-title":"J Endocrinol Invest"},{"key":"12455_CR193","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jns.2015.09.011","volume":"358","author":"R Spataro","year":"2015","unstructured":"Spataro R, Volanti P, Vitale F, Meli F, Colletti T, Di Natale A, La Bella V (2015) Plasma cortisol level in amyotrophic lateral sclerosis. J Neurol Sci 358:282\u2013286","journal-title":"J Neurol Sci"},{"key":"12455_CR194","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1515\/HMBCI.2011.006","volume":"6","author":"GG Monachelli","year":"2011","unstructured":"Monachelli GG, Meyer M, Rodriguez G, Garay L, Sica RE, De Nicola AF, Gonzalez Deniselle MC (2011) Progesterone and cortisol levels in sporadic amyotrophic lateral sclerosis (sALS): correlation with prognostic factors. Horm Mol Biol Clin Investig 6:167\u2013173","journal-title":"Horm Mol Biol Clin Investig"},{"key":"12455_CR195","doi-asserted-by":"crossref","unstructured":"Vercruysse P, Sinniger J, El Oussini H, Scekic-Zahirovic J, Dieterle S, Dengler R, Meyer T, Zierz S, Kassubek J, Fischer W, Dreyhaupt J, Grehl T, Hermann A, Grosskreutz J, Witting A, Van Den Bosch L, Spreux-Varoquaux O, Group GAS, Ludolph AC, Dupuis L (2016) Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis. Brain 139:1106\u20131122","DOI":"10.1093\/brain\/aww004"},{"key":"12455_CR196","doi-asserted-by":"crossref","first-page":"1193483","DOI":"10.3389\/fnagi.2023.1193483","volume":"15","author":"V Gnoni","year":"2023","unstructured":"Gnoni V, Zoccolella S, Giugno A, Urso D, Tamburrino L, Filardi M, Logroscino G (2023) Hypothalamus and amyotrophic lateral sclerosis: potential implications in sleep disorders. Front Aging Neurosci 15:1193483","journal-title":"Front Aging Neurosci"},{"key":"12455_CR197","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11910-020-01047-1","volume":"20","author":"M Boentert","year":"2020","unstructured":"Boentert M (2020) Sleep and sleep disruption in amyotrophic lateral sclerosis. Curr Neurol Neurosci Rep 20:25","journal-title":"Curr Neurol Neurosci Rep"},{"key":"12455_CR198","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/jnnp-2017-316515","volume":"89","author":"M Boentert","year":"2018","unstructured":"Boentert M, Glatz C, Helmle C, Okegwo A, Young P (2018) Prevalence of sleep apnoea and capnographic detection of nocturnal hypoventilation in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 89:418\u2013424","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR199","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2147\/NSS.S183504","volume":"11","author":"M Boentert","year":"2019","unstructured":"Boentert M (2019) Sleep disturbances in patients with amyotrophic lateral sclerosis: current perspectives. Nat Sci Sleep 11:97\u2013111","journal-title":"Nat Sci Sleep"},{"key":"12455_CR200","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1159\/000447560","volume":"17","author":"VN Quaranta","year":"2017","unstructured":"Quaranta VN, Carratu P, Damiani MF, Dragonieri S, Capozzolo A, Cassano A, Resta O (2017) The prognostic role of obstructive sleep apnea at the onset of amyotrophic lateral sclerosis. Neurodegener Dis 17:14\u201321","journal-title":"Neurodegener Dis"},{"key":"12455_CR201","doi-asserted-by":"crossref","first-page":"e89741","DOI":"10.1371\/journal.pone.0089741","volume":"9","author":"A Iranzo","year":"2014","unstructured":"Iranzo A, Fernandez-Arcos A, Tolosa E, Serradell M, Molinuevo JL, Valldeoriola F, Gelpi E, Vilaseca I, Sanchez-Valle R, Llado A, Gaig C, Santamaria J (2014) Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients. PLoS ONE 9:e89741","journal-title":"PLoS ONE"},{"key":"12455_CR202","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1474-4422(14)70051-1","volume":"13","author":"L Sabater","year":"2014","unstructured":"Sabater L, Gaig C, Gelpi E, Bataller L, Lewerenz J, Torres-Vega E, Contreras A, Giometto B, Compta Y, Embid C, Vilaseca I, Iranzo A, Santamaria J, Dalmau J, Graus F (2014) A novel non-rapid-eye movement and rapid-eye-movement parasomnia with sleep breathing disorder associated with antibodies to IgLON5: a case series, characterisation of the antigen, and post-mortem study. Lancet Neurol 13:575\u2013586","journal-title":"Lancet Neurol"},{"key":"12455_CR203","first-page":"23","volume":"16","author":"K Iwanaga","year":"1997","unstructured":"Iwanaga K, Wakabayashi K, Honma Y, Takahashi H (1997) Amyotrophic lateral sclerosis: occurrence of Bunina bodies in the locus ceruleus pigmented neurons. Clin Neuropathol 16:23\u201326","journal-title":"Clin Neuropathol"},{"key":"12455_CR204","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s40478-016-0379-3","volume":"4","author":"K Hayashi","year":"2016","unstructured":"Hayashi K, Mochizuki Y, Takeuchi R, Shimizu T, Nagao M, Watabe K, Arai N, Oyanagi K, Onodera O, Hayashi M, Takahashi H, Kakita A, Isozaki E (2016) Clinicopathological characteristics of patients with amyotrophic lateral sclerosis resulting in a totally locked-in state (communication Stage V). Acta Neuropathol Commun 4:107","journal-title":"Acta Neuropathol Commun"},{"key":"12455_CR205","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.sleep.2016.05.016","volume":"26","author":"M Puligheddu","year":"2016","unstructured":"Puligheddu M, Congiu P, Arico D, Rundo F, Borghero G, Marrosu F, Fantini ML, Ferri R (2016) Isolated rapid eye movement sleep without atonia in amyotrophic lateral sclerosis. Sleep Med 26:16\u201322","journal-title":"Sleep Med"},{"key":"12455_CR206","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/ane.12593","volume":"135","author":"D Lo Coco","year":"2017","unstructured":"Lo Coco D, Puligheddu M, Mattaliano P, Congiu P, Borghero G, Fantini ML, La Bella V, Ferri R (2017) REM sleep behavior disorder and periodic leg movements during sleep in ALS. Acta Neurol Scand 135:219\u2013224","journal-title":"Acta Neurol Scand"},{"key":"12455_CR207","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s41105-020-00296-4","volume":"19","author":"M Choquer","year":"2021","unstructured":"Choquer M, Blasco H, Plantier L, Beltran S, Bakkouche SE, Corcia P, Limousin N (2021) Insomnia is frequent in amyotrophic lateral sclerosis at the time of diagnosis. Sleep Biol Rhythms 19:121\u2013126","journal-title":"Sleep Biol Rhythms"},{"key":"12455_CR208","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s13311-021-01019-4","volume":"18","author":"TR Gossard","year":"2021","unstructured":"Gossard TR, Trotti LM, Videnovic A, St Louis EK (2021) Restless legs syndrome: contemporary diagnosis and treatment. Neurotherapeutics 18:140\u2013155","journal-title":"Neurotherapeutics"},{"key":"12455_CR209","doi-asserted-by":"crossref","unstructured":"Diaconu S, Irincu L, Ungureanu L, Ciopleias B, Tint D, Falup-Pecurariu C (2023) Restless Legs Syndrome in Parkinson's Disease. J Pers Med 2023:13","DOI":"10.3390\/jpm13060915"},{"key":"12455_CR210","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1212\/WNL.0000000000007500","volume":"92","author":"H Alonso-Navarro","year":"2019","unstructured":"Alonso-Navarro H, Garcia-Martin E, Agundez JAG, Jimenez-Jimenez FJ (2019) Association between restless legs syndrome and other movement disorders. Neurology 92:948\u2013964","journal-title":"Neurology"},{"key":"12455_CR211","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/mds.26929","volume":"32","author":"B Hogl","year":"2017","unstructured":"Hogl B, Stefani A (2017) Restless legs syndrome and periodic leg movements in patients with movement disorders: Specific considerations. Mov Disord 32:669\u2013681","journal-title":"Mov Disord"},{"key":"12455_CR212","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000097007","volume":"57","author":"AD Sperfeld","year":"2007","unstructured":"Sperfeld AD, Unrath A, Kassubek J (2007) Restless legs syndrome in hereditary spastic paraparesis. Eur Neurol 57:31\u201335","journal-title":"Eur Neurol"},{"key":"12455_CR213","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3389\/fneur.2018.00735","volume":"9","author":"S Liu","year":"2018","unstructured":"Liu S, Shen D, Tai H, Su N, Ding Q, Fu H, Zhang K, Wang Z, Liu M, Huang Y, Cui L (2018) Restless legs syndrome in chinese patients with sporadic amyotrophic lateral sclerosis. Front Neurol 9:735","journal-title":"Front Neurol"},{"key":"12455_CR214","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/mds.23261","volume":"25","author":"D Lo Coco","year":"2010","unstructured":"Lo Coco D, Piccoli F, La Bella V (2010) Restless legs syndrome in patients with amyotrophic lateral sclerosis. Mov Disord 25:2658\u20132661","journal-title":"Mov Disord"},{"key":"12455_CR215","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/17482968.2011.557736","volume":"12","author":"N Limousin","year":"2011","unstructured":"Limousin N, Blasco H, Corcia P, Arnulf I, Praline J (2011) The high frequency of restless legs syndrome in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 12:303\u2013306","journal-title":"Amyotroph Lateral Scler"},{"key":"12455_CR216","doi-asserted-by":"crossref","unstructured":"Sun X, Zhao X, Liu Q, Liu S, Zhang K, Wang ZL, Yang X, Shang L, Huang Y, Cui L, Zhang X (2020) Study on sleep-wake disorders in patients with genetic and non-genetic amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 2020:1","DOI":"10.1136\/jnnp-2020-324544"},{"key":"12455_CR217","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.4065\/81.10.1345","volume":"81","author":"PR Castillo","year":"2006","unstructured":"Castillo PR, Kaplan J, Lin SC, Fredrickson PA, Mahowald MW (2006) Prevalence of restless legs syndrome among native South Americans residing in coastal and mountainous areas. Mayo Clin Proc 81:1345\u20131347","journal-title":"Mayo Clin Proc"},{"key":"12455_CR218","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/mds.22274","volume":"23","author":"T Nomura","year":"2008","unstructured":"Nomura T, Inoue Y, Kusumi M, Uemura Y, Nakashima K (2008) Prevalence of restless legs syndrome in a rural community in Japan. Mov Disord 23:2363\u20132369","journal-title":"Mov Disord"},{"key":"12455_CR219","first-page":"1069","volume":"32","author":"SJ Cho","year":"2009","unstructured":"Cho SJ, Hong JP, Hahm BJ, Jeon HJ, Chang SM, Cho MJ, Lee HB (2009) Restless legs syndrome in a community sample of Korean adults: prevalence, impact on quality of life, and association with DSM-IV psychiatric disorders. Sleep 32:1069\u20131076","journal-title":"Sleep"},{"key":"12455_CR220","doi-asserted-by":"crossref","unstructured":"Allen RP, Picchietti DL, Auerbach M, Cho YW, Connor JR, Earley CJ, Garcia-Borreguero D, Kotagal S, Manconi M, Ondo W, Ulfberg J, Winkelman JW, International Restless Legs Syndrome Study G (2018) Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome\/Willis\u2013Ekbom disease in adults and children: an IRLSSG task force report. Sleep Med 41:27\u201344","DOI":"10.1016\/j.sleep.2017.11.1126"},{"key":"12455_CR221","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/WCO.0000000000000117","volume":"27","author":"D Garcia-Borreguero","year":"2014","unstructured":"Garcia-Borreguero D, Williams AM (2014) An update on restless legs syndrome (Willis\u2013Ekbom disease): clinical features, pathogenesis and treatment. Curr Opin Neurol 27:493\u2013501","journal-title":"Curr Opin Neurol"},{"key":"12455_CR222","doi-asserted-by":"crossref","first-page":"6741","DOI":"10.1007\/s10072-022-06340-0","volume":"43","author":"S Zago","year":"2022","unstructured":"Zago S, Lorusso L, Aiello EN, Ugolini M, Poletti B, Ticozzi N, Silani V (2022) Cognitive and behavioral involvement in ALS has been known for more than a century. Neurol Sci 43:6741\u20136760","journal-title":"Neurol Sci"},{"key":"12455_CR223","doi-asserted-by":"crossref","first-page":"e984","DOI":"10.1212\/WNL.0000000000008063","volume":"93","author":"A Chio","year":"2019","unstructured":"Chio A, Moglia C, Canosa A, Manera U, Vasta R, Brunetti M, Barberis M, Corrado L, D\u2019Alfonso S, Bersano E, Sarnelli MF, Solara V, Zucchetti JP, Peotta L, Iazzolino B, Mazzini L, Mora G, Calvo A (2019) Cognitive impairment across ALS clinical stages in a population-based cohort. Neurology 93:e984\u2013e994","journal-title":"Neurology"},{"key":"12455_CR224","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jnnp-2015-310734","volume":"87","author":"E Beeldman","year":"2016","unstructured":"Beeldman E, Raaphorst J, Klein Twennaar M, de Visser M, Schmand BA, de Haan RJ (2016) The cognitive profile of ALS: a systematic review and meta-analysis update. J Neurol Neurosurg Psychiatry 87:611\u2013619","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR225","doi-asserted-by":"crossref","unstructured":"Jellinger KA (2023) The Spectrum of Cognitive Dysfunction in Amyotrophic Lateral Sclerosis: An Update. Int J Mol Sci 2023:24","DOI":"10.3390\/ijms241914647"},{"key":"12455_CR226","doi-asserted-by":"crossref","unstructured":"De Marchi F, Carrarini C, De Martino A, Diamanti L, Fasano A, Lupica A, Russo M, Salemme S, Spinelli EG, Bombaci A, Sig N (2021) Cognitive dysfunction in amyotrophic lateral sclerosis: Can we predict it? Neurol Sci 42:2211\u20132222","DOI":"10.1007\/s10072-021-05188-0"},{"key":"12455_CR227","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/WCO.0000000000000862","volume":"33","author":"N Pender","year":"2020","unstructured":"Pender N, Pinto-Grau M, Hardiman O (2020) Cognitive and behavioural impairment in amyotrophic lateral sclerosis. Curr Opin Neurol 33:649\u2013654","journal-title":"Curr Opin Neurol"},{"key":"12455_CR228","doi-asserted-by":"crossref","unstructured":"Woolley S, Goetz R, Factor-Litvak P, Murphy J, Hupf J, Garofalo DC, Lomen-Hoerth C, Andrews H, Heitzman D, Bedlack R, Katz J, Barohn R, Sorenson E, Oskarsson B, Filho AF, Kasarskis E, Mozaffar T, Nations S, Swenson A, Koczon-Jaremko A, Christodoulou G, Mitsumoto H (2018) Longitudinal screening detects cognitive stability and behavioral deterioration in ALS patients. Behav Neurol 2018:5969137","DOI":"10.1155\/2018\/5969137"},{"key":"12455_CR229","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/WCO.0000000000001168","volume":"36","author":"M Benatar","year":"2023","unstructured":"Benatar M, Turner MR, Wuu J (2023) Presymptomatic amyotrophic lateral sclerosis: from characterization to prevention. Curr Opin Neurol 36:360\u2013364","journal-title":"Curr Opin Neurol"},{"key":"12455_CR230","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/21678421.2020.1797090","volume":"21","author":"JA Saxon","year":"2020","unstructured":"Saxon JA, Thompson JC, Harris JM, Ealing J, Hamdalla H, Chaouch A, Young C, Blackburn D, Majeed T, Gall C, Richardson AMT, Langheinrich T, Jones M, Snowden JS (2020) The Edinburgh Cognitive and Behavioral ALS Screen (ECAS) in frontotemporal dementia. Amyotroph Lateral Scler Frontotemporal Degener 21:606\u2013613","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR231","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1080\/21678421.2020.1801751","volume":"22","author":"Y Watanabe","year":"2021","unstructured":"Watanabe Y, Ogino M, Ichikawa H, Hanajima R, Nakashima K (2021) The Edinburgh cognitive and behavioural ALS screen (ECAS) for Japanese ALS and FTD patients. Amyotroph Lateral Scler Frontotemporal Degener 22:66\u201372","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR232","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/17482961003727954","volume":"11","author":"SC Woolley","year":"2010","unstructured":"Woolley SC, York MK, Moore DH, Strutt AM, Murphy J, Schulz PE, Katz JS (2010) Detecting frontotemporal dysfunction in ALS: utility of the ALS cognitive behavioral screen (ALS-CBS). Amyotroph Lateral Scler 11:303\u2013311","journal-title":"Amyotroph Lateral Scler"},{"key":"12455_CR233","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/21678421.2015.1125500","volume":"17","author":"J Turon-Sans","year":"2016","unstructured":"Turon-Sans J, Gascon-Bayarri J, Rene R, Rico I, Gamez C, Paipa A, Povedano M (2016) Cognitive impairment in ALS patients and validation of the Spanish version of the ALS-CBS test. Amyotroph Lateral Scler Frontotemporal Degener 17:221\u2013227","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR234","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/21678421.2015.1030430","volume":"16","author":"E Niven","year":"2015","unstructured":"Niven E, Newton J, Foley J, Colville S, Swingler R, Chandran S, Bak TH, Abrahams S (2015) Validation of the Edinburgh Cognitive and Behavioural Amyotrophic Lateral Sclerosis Screen (ECAS): a cognitive tool for motor disorders. Amyotroph Lateral Scler Frontotemporal Degener 16:172\u2013179","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR235","doi-asserted-by":"crossref","first-page":"1107001","DOI":"10.3389\/fpsyg.2022.1107001","volume":"13","author":"EN Aiello","year":"2022","unstructured":"Aiello EN, Solca F, Greco LC, La Tona A, Torre S, Carelli L, Morelli C, Doretti A, Colombo E, Messina S, Pain D, Radici A, Lizio A, Casiraghi J, Cerri F, Brugnera A, Compare A, Woolley S, Murphy J, Tremolizzo L, Appollonio I, Verde F, Sansone VA, Lunetta C, Silani V, Ticozzi N, Poletti B (2022) Standardization of the Italian ALS-CBS caregiver behavioral questionnaire. Front Psychol 13:1107001","journal-title":"Front Psychol"},{"key":"12455_CR236","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3109\/21678421.2013.805784","volume":"15","author":"S Abrahams","year":"2014","unstructured":"Abrahams S, Newton J, Niven E, Foley J, Bak TH (2014) Screening for cognition and behaviour changes in ALS. Amyotroph Lateral Scler Frontotemporal Degener 15:9\u201314","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR237","doi-asserted-by":"crossref","first-page":"e0200953","DOI":"10.1371\/journal.pone.0200953","volume":"13","author":"B Poletti","year":"2018","unstructured":"Poletti B, Carelli L, Faini A, Solca F, Meriggi P, Lafronza A, Ciringione L, Pedroli E, Ticozzi N, Ciammola A, Cipresso P, Riva G, Silani V (2018) The Arrows and Colors Cognitive Test (ACCT): a new verbal-motor free cognitive measure for executive functions in ALS. PLoS ONE 13:e0200953","journal-title":"PLoS ONE"},{"key":"12455_CR238","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000346389","volume":"35","author":"S Savage","year":"2013","unstructured":"Savage S, Hsieh S, Leslie F, Foxe D, Piguet O, Hodges JR (2013) Distinguishing subtypes in primary progressive aphasia: application of the Sydney language battery. Dement Geriatr Cogn Disord 35:208\u2013218","journal-title":"Dement Geriatr Cogn Disord"},{"key":"12455_CR239","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1469-7610.1982.tb00045.x","volume":"23","author":"DV Bishop","year":"1982","unstructured":"Bishop DV (1982) Comprehension of spoken, written and signed sentences in childhood language disorders. J Child Psychol Psychiatry 23:1\u201320","journal-title":"J Child Psychol Psychiatry"},{"key":"12455_CR240","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1212\/WNL.55.11.1621","volume":"55","author":"B Dubois","year":"2000","unstructured":"Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a frontal assessment battery at bedside. Neurology 55:1621\u20131626","journal-title":"Neurology"},{"key":"12455_CR241","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cortex.2017.06.023","volume":"94","author":"R Radakovic","year":"2017","unstructured":"Radakovic R, Stephenson L, Newton J, Crockford C, Swingler R, Chandran S, Abrahams S (2017) Multidimensional apathy and executive dysfunction in amyotrophic lateral sclerosis. Cortex 94:142\u2013151","journal-title":"Cortex"},{"key":"12455_CR242","doi-asserted-by":"crossref","first-page":"1133758","DOI":"10.3389\/fnins.2023.1133758","volume":"17","author":"V Castelnovo","year":"2023","unstructured":"Castelnovo V, Canu E, De Mattei F, Filippi M, Agosta F (2023) Basal ganglia alterations in amyotrophic lateral sclerosis. Front Neurosci 17:1133758","journal-title":"Front Neurosci"},{"key":"12455_CR243","doi-asserted-by":"crossref","first-page":"103400","DOI":"10.1016\/j.nicl.2023.103400","volume":"38","author":"A Nigri","year":"2023","unstructured":"Nigri A, Umberto M, Stanziano M, Ferraro S, Fedeli D, Medina Carrion JP, Palermo S, Lequio L, Denegri F, Agosta F, Filippi M, Valentini MC, Canosa A, Calvo A, Chio A, Bruzzone MG, Moglia C (2023) C9orf72 ALS mutation carriers show extensive cortical and subcortical damage compared to matched wild-type ALS patients. Neuroimage Clin 38:103400","journal-title":"Neuroimage Clin"},{"key":"12455_CR244","first-page":"306","volume":"111","author":"D Renard","year":"2011","unstructured":"Renard D, Collombier L, Castelnovo G, Fourcade G, Kotzki PO, LaBauge P (2011) Brain FDG-PET changes in ALS and ALS-FTD. Acta Neurol Belg 111:306\u2013309","journal-title":"Acta Neurol Belg"},{"key":"12455_CR245","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1212\/WNL.0000000000002242","volume":"86","author":"A Canosa","year":"2016","unstructured":"Canosa A, Pagani M, Cistaro A, Montuschi A, Iazzolino B, Fania P, Cammarosano S, Ilardi A, Moglia C, Calvo A, Chio A (2016) 18F-FDG-PET correlates of cognitive impairment in ALS. Neurology 86:44\u201349","journal-title":"Neurology"},{"key":"12455_CR246","doi-asserted-by":"crossref","first-page":"1132808","DOI":"10.3389\/fnagi.2023.1132808","volume":"15","author":"F Verde","year":"2023","unstructured":"Verde F, Milone I, Colombo E, Maranzano A, Solca F, Torre S, Doretti A, Gentile F, Manini A, Bonetti R, Peverelli S, Messina S, Maderna L, Morelli C, Poletti B, Ratti A, Silani V, Ticozzi N (2023) Phenotypic correlates of serum neurofilament light chain levels in amyotrophic lateral sclerosis. Front Aging Neurosci 15:1132808","journal-title":"Front Aging Neurosci"},{"key":"12455_CR247","doi-asserted-by":"crossref","first-page":"991143","DOI":"10.3389\/fneur.2022.991143","volume":"13","author":"Z Gong","year":"2022","unstructured":"Gong Z, Gao L, Lu Y, Wang Z (2022) CSF p-tau as a potential cognition impairment biomarker in ALS. Front Neurol 13:991143","journal-title":"Front Neurol"},{"key":"12455_CR248","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/brain\/awx370","volume":"141","author":"D Brenner","year":"2018","unstructured":"Brenner D, Yilmaz R, Muller K, Grehl T, Petri S, Meyer T, Grosskreutz J, Weydt P, Ruf W, Neuwirth C, Weber M, Pinto S, Claeys KG, Schrank B, Jordan B, Knehr A, Gunther K, Hubers A, Zeller D, Kubisch C, Jablonka S, Sendtner M, Klopstock T, de Carvalho M, Sperfeld A, Borck G, Volk AE, Dorst J, Weis J, Otto M, Schuster J, Del Tredici K, Braak H, Danzer KM, Freischmidt A, Meitinger T, Strom TM, Ludolph AC, Andersen PM, Weishaupt JH, German ALSnMNDNET (2018) Hot-spot KIF5A mutations cause familial ALS. Brain 141:688\u2013697","journal-title":"Brain"},{"key":"12455_CR249","doi-asserted-by":"crossref","unstructured":"Ghasemi M, Brown RH Jr (2018) Genetics of amyotrophic lateral sclerosis. Cold Spring Harb Perspect Med 2018:8","DOI":"10.1101\/cshperspect.a024125"},{"key":"12455_CR250","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.tig.2018.03.001","volume":"34","author":"HP Nguyen","year":"2018","unstructured":"Nguyen HP, Van Broeckhoven C, van der Zee J (2018) ALS genes in the genomic era and their implications for FTD. Trends Genet 34:404\u2013423","journal-title":"Trends Genet"},{"key":"12455_CR251","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3109\/21678421.2014.969275","volume":"16","author":"A Geronimo","year":"2015","unstructured":"Geronimo A, Stephens HE, Schiff SJ, Simmons Z (2015) Acceptance of brain-computer interfaces in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 16:258\u2013264","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR252","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4140\/TCP.n.2014.264","volume":"29","author":"E Patatanian","year":"2014","unstructured":"Patatanian E, Casselman J (2014) Dextromethorphan\/quinidine for the treatment of pseudobulbar affect. Consult Pharm 29:264\u2013269","journal-title":"Consult Pharm"},{"key":"12455_CR253","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1176\/jnp.12.1.100","volume":"12","author":"S McCullagh","year":"2000","unstructured":"McCullagh S, Feinstein A (2000) Treatment of pathological affect: variability of response for laughter and crying. J Neuropsychiatry Clin Neurosci 12:100\u2013102","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"12455_CR254","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s13311-022-01247-2","volume":"19","author":"BD Boros","year":"2022","unstructured":"Boros BD, Schoch KM, Kreple CJ, Miller TM (2022) Antisense oligonucleotides for the study and treatment of ALS. Neurotherapeutics 19:1145\u20131158","journal-title":"Neurotherapeutics"},{"key":"12455_CR255","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41591-021-01615-z","volume":"28","author":"VA Korobeynikov","year":"2022","unstructured":"Korobeynikov VA, Lyashchenko AK, Blanco-Redondo B, Jafar-Nejad P, Shneider NA (2022) Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis. Nat Med 28:104\u2013116","journal-title":"Nat Med"},{"key":"12455_CR256","doi-asserted-by":"crossref","unstructured":"Miller TM, Cudkowicz ME, Genge A, Shaw PJ, Sobue G, Bucelli RC, Chio A, Van Damme P, Ludolph AC, Glass JD, Andrews JA, Babu S, Benatar M, McDermott CJ, Cochrane T, Chary S, Chew S, Zhu H, Wu F, Nestorov I, Graham D, Sun P, McNeill M, Fanning L, Ferguson TA, Fradette S, Valor, Group OLEW (2022) Trial of antisense oligonucleotide tofersen for SOD1 ALS. N Engl J Med 387:1099\u20131110","DOI":"10.1056\/NEJMoa2204705"},{"key":"12455_CR257","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41591-021-01557-6","volume":"28","author":"H Tran","year":"2022","unstructured":"Tran H, Moazami MP, Yang H, McKenna-Yasek D, Douthwright CL, Pinto C, Metterville J, Shin M, Sanil N, Dooley C, Puri A, Weiss A, Wightman N, Gray-Edwards H, Marosfoi M, King RM, Kenderdine T, Fabris D, Bowser R, Watts JK, Brown RH Jr (2022) Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide. Nat Med 28:117\u2013124","journal-title":"Nat Med"},{"key":"12455_CR258","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jad.2021.03.015","volume":"287","author":"ME Heidari","year":"2021","unstructured":"Heidari ME, Nadali J, Parouhan A, Azarafraz M, Tabatabai SM, Irvani SSN, Eskandari F, Gharebaghi A (2021) Prevalence of depression among amyotrophic lateral sclerosis (ALS) patients: a systematic review and meta-analysis. J Affect Disord 287:182\u2013190","journal-title":"J Affect Disord"},{"key":"12455_CR259","doi-asserted-by":"crossref","first-page":"122780","DOI":"10.1016\/j.jns.2023.122780","volume":"455","author":"BJ Larsson","year":"2023","unstructured":"Larsson BJ, Nordin K, Nygren I (2023) Symptoms of anxiety and depression in patients with amyotrophic lateral sclerosis and their relatives during the disease trajectory. J Neurol Sci 455:122780","journal-title":"J Neurol Sci"},{"key":"12455_CR260","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1212\/WNL.0000000000002465","volume":"86","author":"NJ Thakore","year":"2016","unstructured":"Thakore NJ, Pioro EP (2016) Depression in ALS in a large self-reporting cohort. Neurology 86:1031\u20131038","journal-title":"Neurology"},{"key":"12455_CR261","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1212\/WNL.0000000000004179","volume":"89","author":"E Longinetti","year":"2017","unstructured":"Longinetti E, Mariosa D, Larsson H, Ye W, Ingre C, Almqvist C, Lichtenstein P, Piehl F, Fang F (2017) Neurodegenerative and psychiatric diseases among families with amyotrophic lateral sclerosis. Neurology 89:578\u2013585","journal-title":"Neurology"},{"key":"12455_CR262","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/14660820410021294","volume":"5","author":"T Hillemacher","year":"2004","unstructured":"Hillemacher T, Grassel E, Tigges S, Bleich S, Neundorfer B, Kornhuber J, Hecht MJ (2004) Depression and bulbar involvement in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 5:245\u2013249","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"key":"12455_CR263","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/ane.13073","volume":"139","author":"F De Marchi","year":"2019","unstructured":"De Marchi F, Sarnelli MF, Solara V, Bersano E, Cantello R, Mazzini L (2019) Depression and risk of cognitive dysfunctions in amyotrophic lateral sclerosis. Acta Neurol Scand 139:438\u2013445","journal-title":"Acta Neurol Scand"},{"key":"12455_CR264","doi-asserted-by":"crossref","first-page":"9119","DOI":"10.1038\/s41598-021-88755-x","volume":"11","author":"Y Wang","year":"2021","unstructured":"Wang Y, Ye S, Chen L, Tang L, Fan D (2021) Loss of appetite in patients with amyotrophic lateral sclerosis is associated with weight loss and anxiety\/depression. Sci Rep 11:9119","journal-title":"Sci Rep"},{"key":"12455_CR265","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jad.2020.08.066","volume":"277","author":"MH Silva-Moraes","year":"2020","unstructured":"Silva-Moraes MH, Bispo-Torres AC, Barouh JL, Lucena PH, Armani-Franceschi G, Dorea-Bandeira I, Vieira F, Miranda-Scippa A, Quarantini LC, Lucena R, Bandeira ID (2020) Suicidal behavior in individuals with amyotrophic lateral sclerosis: a systematic review. J Affect Disord 277:688\u2013696","journal-title":"J Affect Disord"},{"key":"12455_CR266","doi-asserted-by":"crossref","first-page":"620198","DOI":"10.3389\/fneur.2021.620198","volume":"12","author":"S Benbrika","year":"2021","unstructured":"Benbrika S, Doidy F, Carluer L, Mondou A, Pelerin A, Eustache F, Viader F, Desgranges B (2021) Longitudinal study of cognitive and emotional alterations in amyotrophic lateral sclerosis: clinical and imaging data. Front Neurol 12:620198","journal-title":"Front Neurol"},{"key":"12455_CR267","doi-asserted-by":"crossref","unstructured":"Ostuzzi G, Matcham F, Dauchy S, Barbui C, Hotopf M (2018) Antidepressants for the treatment of depression in people with cancer. Cochrane Database Syst Rev 4:CD011006","DOI":"10.1002\/14651858.CD011006.pub3"},{"key":"12455_CR268","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3109\/21678421.2015.1062515","volume":"16","author":"RL Gould","year":"2015","unstructured":"Gould RL, Coulson MC, Brown RG, Goldstein LH, Al-Chalabi A, Howard RJ (2015) Psychotherapy and pharmacotherapy interventions to reduce distress or improve well-being in people with amyotrophic lateral sclerosis: a systematic review. Amyotroph Lateral Scler Frontotemporal Degener 16:293\u2013302","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR269","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s12883-022-02950-5","volume":"22","author":"RL Gould","year":"2022","unstructured":"Gould RL, Thompson BJ, Rawlinson C, Kumar P, White D, Serfaty MA, Graham CD, McCracken LM, Bursnall M, Bradburn M, Young T, Howard RJ, Al-Chalabi A, Goldstein LH, Lawrence V, Cooper C, Shaw PJ, McDermott CJ (2022) A randomised controlled trial of acceptance and commitment therapy plus usual care compared to usual care alone for improving psychological health in people with motor neuron disease (COMMEND): study protocol. BMC Neurol 22:431","journal-title":"BMC Neurol"},{"key":"12455_CR270","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.3389\/fneur.2018.01035","volume":"9","author":"MR Grabler","year":"2018","unstructured":"Grabler MR, Weyen U, Juckel G, Tegenthoff M, Mavrogiorgou-Juckel P (2018) Death anxiety and depression in amyotrophic lateral sclerosis patients and their primary caregivers. Front Neurol 9:1035","journal-title":"Front Neurol"},{"key":"12455_CR271","doi-asserted-by":"crossref","unstructured":"Miyagawa T, Brushaber D, Syrjanen J, Kremers W, Fields J, Forsberg LK, Heuer HW, Knopman D, Kornak J, Boxer A, Rosen H, Boeve B, Consortium AL (2020) Use of the CDR(R) plus NACC FTLD in mild FTLD: Data from the ARTFL\/LEFFTDS consortium. Alzheimers Dement 16:79\u201390","DOI":"10.1016\/j.jalz.2019.05.013"},{"key":"12455_CR272","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1007\/s00415-022-11442-y","volume":"270","author":"K Samra","year":"2023","unstructured":"Samra K, MacDougall AM, Peakman G, Bouzigues A, Bocchetta M, Cash DM, Greaves CV, Convery RS, van Swieten JC, Jiskoot L, Seelaar H, Moreno F, Sanchez-Valle R, Laforce R, Graff C, Masellis M, Tartaglia C, Rowe JB, Borroni B, Finger E, Synofzik M, Galimberti D, Vandenberghe R, de Mendonca A, Butler CR, Gerhard A, Ducharme S, Le Ber I, Tiraboschi P, Santana I, Pasquier F, Levin J, Otto M, Sorbi S, Rohrer JD, Russell LL, Genetic FTDI (2023) Motor symptoms in genetic frontotemporal dementia: developing a new module for clinical rating scales. J Neurol 270:1466\u20131477","journal-title":"J Neurol"},{"key":"12455_CR273","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mus.27744","volume":"67","author":"SA Goutman","year":"2023","unstructured":"Goutman SA, Boss J, Iyer G, Habra H, Savelieff MG, Karnovsky A, Mukherjee B, Feldman EL (2023) Body mass index associates with amyotrophic lateral sclerosis survival and metabolomic profiles. Muscle Nerve 67:208\u2013216","journal-title":"Muscle Nerve"},{"key":"12455_CR274","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1136\/jnnp.2010.211474","volume":"82","author":"B Marin","year":"2011","unstructured":"Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, Nicol M, Preux PM, Couratier P (2011) Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry 82:628\u2013634","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR275","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1136\/jnnp-2020-322909","volume":"91","author":"MR Janse van Mantgem","year":"2020","unstructured":"Janse van Mantgem MR, van Eijk RPA, van der Burgh HK, Tan HHG, Westeneng HJ, van Es MA, Veldink JH, van den Berg LH (2020) Prognostic value of weight loss in patients with amyotrophic lateral sclerosis: a population-based study. J Neurol Neurosurg Psychiatry 91:867\u2013875","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR276","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1111\/ene.15584","volume":"30","author":"K Xia","year":"2023","unstructured":"Xia K, Witzel S, Witzel C, Klose V, Fan D, Ludolph AC, Dorst J (2023) Mutation-specific metabolic profiles in presymptomatic amyotrophic lateral sclerosis. Eur J Neurol 30:87\u201395","journal-title":"Eur J Neurol"},{"key":"12455_CR277","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10654-017-0318-z","volume":"32","author":"RS Peter","year":"2017","unstructured":"Peter RS, Rosenbohm A, Dupuis L, Brehme T, Kassubek J, Rothenbacher D, Nagel G, Ludolph AC (2017) Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia. Eur J Epidemiol 32:901\u2013908","journal-title":"Eur J Epidemiol"},{"key":"12455_CR278","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/aje\/kww140","volume":"185","author":"D Mariosa","year":"2017","unstructured":"Mariosa D, Beard JD, Umbach DM, Bellocco R, Keller J, Peters TL, Allen KD, Ye W, Sandler DP, Schmidt S, Fang F, Kamel F (2017) Body mass index and amyotrophic lateral sclerosis: a study of US military veterans. Am J Epidemiol 185:362\u2013371","journal-title":"Am J Epidemiol"},{"key":"12455_CR279","doi-asserted-by":"crossref","unstructured":"Kandler K, Witzel S, Eder K, Rothenbacher D, Nagel G, Peter RS, Schuster J, Dorst J, Rosenbohm A, Ludolph AC, Group ALSRS (2022) Phenotyping of the thoracic-onset variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 93:563\u2013565","DOI":"10.1136\/jnnp-2021-326712"},{"key":"12455_CR280","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/jnnp-2018-319611","volume":"90","author":"C Moglia","year":"2019","unstructured":"Moglia C, Calvo A, Grassano M, Canosa A, Manera U, D\u2019Ovidio F, Bombaci A, Bersano E, Mazzini L, Mora G, Chio A, Piemonte, Valle d\u2019Aosta Register for ALS (2019) Early weight loss in amyotrophic lateral sclerosis: outcome relevance and clinical correlates in a population-based cohort. J Neurol Neurosurg Psychiatry 90:666\u2013673","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR281","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuro.2016.06.015","volume":"61","author":"MD Wang","year":"2017","unstructured":"Wang MD, Little J, Gomes J, Cashman NR, Krewski D (2017) Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. Neurotoxicology 61:101\u2013130","journal-title":"Neurotoxicology"},{"key":"12455_CR282","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s00415-019-09276-2","volume":"266","author":"T Shimizu","year":"2019","unstructured":"Shimizu T, Nakayama Y, Matsuda C, Haraguchi M, Bokuda K, Ishikawa-Takata K, Kawata A, Isozaki E (2019) Prognostic significance of body weight variation after diagnosis in ALS: a single-centre prospective cohort study. J Neurol 266:1412\u20131420","journal-title":"J Neurol"},{"key":"12455_CR283","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/s41582-023-00845-8","volume":"19","author":"A Ludolph","year":"2023","unstructured":"Ludolph A, Dupuis L, Kasarskis E, Steyn F, Ngo S, McDermott C (2023) Nutritional and metabolic factors in amyotrophic lateral sclerosis. Nat Rev Neurol 19:511\u2013524","journal-title":"Nat Rev Neurol"},{"key":"12455_CR284","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/mus.26749","volume":"61","author":"T Mezoian","year":"2020","unstructured":"Mezoian T, Belt E, Garry J, Hubbard J, Breen CT, Miller L, Levine-Weinberg M, Nalipinski P, Sullivan S, Chan J, Wills AM (2020) Loss of appetite in amyotrophic lateral sclerosis is associated with weight loss and decreased calorie consumption independent of dysphagia. Muscle Nerve 61:230\u2013234","journal-title":"Muscle Nerve"},{"key":"12455_CR285","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/mus.27694","volume":"66","author":"M Sarmet","year":"2022","unstructured":"Sarmet M, Kabani A, Maragakis NJ, Mehta AK (2022) Appetite and quality of life in amyotrophic lateral sclerosis: a scoping review. Muscle Nerve 66:653\u2013660","journal-title":"Muscle Nerve"},{"key":"12455_CR286","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1080\/21678421.2019.1621346","volume":"20","author":"ST Ngo","year":"2019","unstructured":"Ngo ST, van Eijk RPA, Chachay V, van den Berg LH, McCombe PA, Henderson RD, Steyn FJ (2019) Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 20:497\u2013505","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"12455_CR287","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/s00415-009-5100-z","volume":"256","author":"C Bouteloup","year":"2009","unstructured":"Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, Couratier P (2009) Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256:1236\u20131242","journal-title":"J Neurol"},{"key":"12455_CR288","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/jnnp-2021-326184","volume":"93","author":"M Cattaneo","year":"2022","unstructured":"Cattaneo M, Jesus P, Lizio A, Fayemendy P, Guanziroli N, Corradi E, Sansone V, Leocani L, Filippi M, Riva N, Corcia P, Couratier P, Lunetta C (2022) The hypometabolic state: a good predictor of a better prognosis in amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 93:41\u201347","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"12455_CR289","doi-asserted-by":"crossref","first-page":"117257","DOI":"10.1016\/j.jns.2020.117257","volume":"420","author":"P Fayemendy","year":"2021","unstructured":"Fayemendy P, Marin B, Labrunie A, Boirie Y, Walrand S, Achamrah N, Coeffier M, Preux PM, Lautrette G, Desport JC, Couratier P, Jesus P (2021) Hypermetabolism is a reality in amyotrophic lateral sclerosis compared to healthy subjects. J Neurol Sci 420:117257","journal-title":"J Neurol Sci"},{"key":"12455_CR290","doi-asserted-by":"crossref","first-page":"110805","DOI":"10.1016\/j.nut.2020.110805","volume":"77","author":"P Jesus","year":"2020","unstructured":"Jesus P, Fayemendy P, Marin B, Nicol M, Sourisseau H, Boirie Y, Walrand S, Achamrah N, Coeffier M, Preux PM, Lautrette G, Couratier P, Desport JC (2020) Increased resting energy expenditure compared with predictive theoretical equations in amyotrophic lateral sclerosis. Nutrition 77:110805","journal-title":"Nutrition"},{"key":"12455_CR291","doi-asserted-by":"crossref","unstructured":"Kasarskis EJ, Mendiondo MS, Matthews DE, Mitsumoto H, Tandan R, Simmons Z, Bromberg MB, Kryscio RJ, Group ALSNNS (2014) Estimating daily energy expenditure in individuals with amyotrophic lateral sclerosis. Am J Clin Nutr 99:792\u2013803","DOI":"10.3945\/ajcn.113.069997"},{"key":"12455_CR292","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.mito.2005.01.002","volume":"5","author":"G Manfredi","year":"2005","unstructured":"Manfredi G, Xu Z (2005) Mitochondrial dysfunction and its role in motor neuron degeneration in ALS. Mitochondrion 5:77\u201387","journal-title":"Mitochondrion"},{"key":"12455_CR293","doi-asserted-by":"crossref","first-page":"103396","DOI":"10.1016\/j.mcn.2019.103396","volume":"100","author":"J Gao","year":"2019","unstructured":"Gao J, Wang L, Yan T, Perry G, Wang X (2019) TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Mol Cell Neurosci 100:103396","journal-title":"Mol Cell Neurosci"},{"key":"12455_CR294","doi-asserted-by":"crossref","first-page":"5844","DOI":"10.1007\/s12035-019-1485-6","volume":"56","author":"TW Tefera","year":"2019","unstructured":"Tefera TW, Bartlett K, Tran SS, Hodson MP, Borges K (2019) Impaired pentose phosphate pathway in the spinal cord of the hSOD1(G93A) mouse model of amyotrophic lateral sclerosis. Mol Neurobiol 56:5844\u20135855","journal-title":"Mol Neurobiol"},{"key":"12455_CR295","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1093\/brain\/awz302","volume":"142","author":"SP Allen","year":"2019","unstructured":"Allen SP, Hall B, Woof R, Francis L, Gatto N, Shaw AC, Myszczynska M, Hemingway J, Coldicott I, Willcock A, Job L, Hughes RM, Boschian C, Bayatti N, Heath PR, Bandmann O, Mortiboys H, Ferraiuolo L, Shaw PJ (2019) C9orf72 expansion within astrocytes reduces metabolic flexibility in amyotrophic lateral sclerosis. Brain 142:3771\u20133790","journal-title":"Brain"},{"key":"12455_CR296","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1177\/0271678X18764775","volume":"39","author":"TW Tefera","year":"2019","unstructured":"Tefera TW, Borges K (2019) Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the hSOD1(G93A) mouse model of amyotrophic lateral sclerosis. J Cereb Blood Flow Metab 39:1710\u20131724","journal-title":"J Cereb Blood Flow Metab"},{"key":"12455_CR297","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s40478-014-0171-1","volume":"2","author":"MD Cykowski","year":"2014","unstructured":"Cykowski MD, Takei H, Schulz PE, Appel SH, Powell SZ (2014) TDP-43 pathology in the basal forebrain and hypothalamus of patients with amyotrophic lateral sclerosis. Acta Neuropathol Commun 2:171","journal-title":"Acta Neuropathol Commun"},{"key":"12455_CR298","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nm.2421","volume":"17","author":"S Diano","year":"2011","unstructured":"Diano S, Liu ZW, Jeong JK, Dietrich MO, Ruan HB, Kim E, Suyama S, Kelly K, Gyengesi E, Arbiser JL, Belsham DD, Sarruf DA, Schwartz MW, Bennett AM, Shanabrough M, Mobbs CV, Yang X, Gao XB, Horvath TL (2011) Peroxisome proliferation-associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Nat Med 17:1121\u20131127","journal-title":"Nat Med"},{"key":"12455_CR299","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1471-2466-14-17","volume":"14","author":"M Georges","year":"2014","unstructured":"Georges M, Morelot-Panzini C, Similowski T, Gonzalez-Bermejo J (2014) Noninvasive ventilation reduces energy expenditure in amyotrophic lateral sclerosis. BMC Pulm Med 14:17","journal-title":"BMC Pulm Med"},{"key":"12455_CR300","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2009.200642","volume":"81","author":"M Weber","year":"2010","unstructured":"Weber M, Goldman B, Truniger S (2010) Tetrahydrocannabinol (THC) for cramps in amyotrophic lateral sclerosis: a randomised, double-blind crossover trial. J Neurol Neurosurg Psychiatry 81:1135\u20131140","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12455-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-024-12455-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-024-12455-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T10:45:46Z","timestamp":1720521946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-024-12455-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":300,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["12455"],"URL":"https:\/\/doi.org\/10.1007\/s00415-024-12455-5","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"17 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"BB, M-B.B. and J.H.-B received compensation for travel expenses from ITF Pharma GmbH outside of the submitted work. SP has received speaker fees, non-financial support and research support from Biogen, Roche, AL-S Pharma, Amylyx, Cytokinetics, Ferrer, ITF-Pharma, and Sanofi and served on advisory boards of Amylyx, Biogen, Roche, Zambon and ITF Pharma outside of the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The manuscript does not contain clinical studies or patient data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}